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T regulatory cells are critical in the maintenance of self-tolerance, immune homeostasis and 
regulation of the immune system. Cytokine signalling is a dominant component of 
environmental signals which controls the function of Forkhead box P3 (Foxp3) regulatory T 
cells. This thesis addressed the hypothesis that interleukin-4 receptor alpha (IL-4Rα) signalling 
on T regulatory cells (T reg) play a role in the stability of T reg cells. Loss of IL-4Rα signalling 
on T reg cells may shift the immune balance from a Foxp3+ T reg to a Th1 effector function 
essential for Th1 disease outcome. Regulatory cells have a major function to dampen cytokine 
production; however, this role can be detrimental for host-protective immune responses in 
diseases such as tuberculosis. Here, we used two Th1 models of intracellular pathogens Listeria 
monocytogenes (Lm) and Mycobacterium tuberculosis (Mtb), to understand the role of IL-4Rα 
signalling on Foxp3+ T regulatory cells. Infection studies with L. monocytogenes demonstrated 
an impairment of T reg responses, with a decreased bacterial burden and diminished pathology 
both in the liver and spleen at 7 days post-infection, ultimately translated in better survival. 
Mechanistically, enhanced Th1 signature with the characteristic T-bet transcriptional factor and 
increased effector T cells producing IFN-γ, IL-2 following ex-vivo stimulation with 
PMA/Ionomycin, and heat-killed Lm (HKLM) were observed in Foxp3creIL-4Rα-/lox mice. 
Furthermore, CD8+ T cells of Foxp3creIL-4Rα-/lox mice showed increased cytotoxicity 
(Granzyme-B secretion) with higher proliferation capacity (Ki-67), better survival (Bcl-2) and 
decreased apoptosis (activated caspase3), suggesting contribution towards the observed 
protection against listeriosis. Subsequently, we investigated the role of IL-4Rα on Foxp3 T reg 
cells in Mycobacterium tuberculosis infection. To our surprise, in contrast to Lm infection, 
survival Survival of Mtb-infected Foxp3creIL-4Rα-/lox mice was similar to littermate control 
following infection with an intermediate dose of Mtb (H37Rv). We observed no differences in 
acute and chronic stages of infection in bacterial burden and histopathological scores in 
Foxp3creIL-4Rα-/lox mice when compared to littermate control animals in acute and chronic 
stages of infection. Importantly, Mtb infected FoxP3creIL-4Rα-/lox mice, exhibited significantly 





















1.1 Literature Review 
1.1.1 The Immune system 
 
The Immune system consists of cells, organs, tissues and protein that enables the body to fight 
against pathogens including viruses, bacteria, parasites and others including dead cells destined 
to be cleared by the system. The immune system is made of the innate and adaptive arms 
(Murphy 2011) 
1.1.2 Innate Immunity 
 
The Innate immunity is the first line of defence during the invasion by a pathogen, it was 
originally thought to be non-specific, but can distinguish between self and invading pathogens 
or non-self that potentially cause damage. The first line of the immune defence comprises of 
the skin, while inside the body mast cells, eosinophils, basophils, Natural killer cells are 
involved. Most importantly, phagocytic cells including macrophages, neutrophils and dendritic 
cells, identify and eliminate invading pathogens. Pattern-recognition receptors (PRRS) on the 
surface of cells, recognise components on microbes known as pathogen-associated molecular 
patterns (PAMPs). In Mycobacterium tuberculosis, the lipids and polysaccharides of the cell 
wall, are recognised mainly by Toll-like receptor 2(TLR2) and TLR4, which are also known to 
play a role towards the initiation of the adaptive immunity during Mycobacterium tuberculosis 
(Mtb) infection. Control L monocytogenes, on the other hand, depends on the activation and 
signalling through TLR2, though TLR5, TLR9 has been shown to also play an important role. 
Specific interaction of PRR and PAMPs leads to the activation of cascade signalling pathways 
leading to host-protective responses. This leads to the recruitment of other cells into the site of 
infection through the release of chemokines and cytokines. Macrophages are the major 
phagocytes in the immune system, there are various forms depending on their location and 
origin. Macrophages are distributed throughout the body, for example, we have alveolar 
macrophage which is resident on the lungs and established during embryonic development with 
tissue-specific function from a foetal liver origin and monocyte-derived macrophage which are 
differentiated into macrophages during inflammatory conditions. Depending on the 
pathogen/macrophage interaction, macrophages differentiate into two different subsets, 
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classically activated macrophages or M1 macrophages, or alternatively activate macrophages 
or M2 macrophages. M1 macrophages are induced by Th1 cytokines interferon-gamma (IFN-
γ), or by lipopolysaccharide (LPS). Uptake of the intracellular pathogen by macrophages 
results in the production of reactive nitrogen intermediates (RNIs) such as nitric oxide (NO) 
and reactive oxygen species (Gordon 2003). On the contrary, M2 macrophages induce arginase 
1 production and decrease NO and have regulatory activities with wound healing functions 
(Figure 1.1) (Classen et al. 2009; Martinez et al. 2009), with a combination of IL-1β or LPS or 
IL-10, TGF-β producing cytokines contribute towards immune regulation balance. 
 
Figure 1. 1 Schematic illustration of Pathogen interaction with macrophages: Classical activation of 
macrophages (M1 macrophages induced) by Th1 cytokines in combination with stimuli (IFN-γ or GM-
CSF) and/or with microbial components like lipopolysaccharide (LPS) induce a pro-inflammatory 
phenotype. M2 Macrophages (alternative) activated by Th2 cytokines (IL-4/IL-13). [Adapted and 




Neutrophils or polymorphonuclear neutrophils (PMN) are the most abundant group of innate 
cells, they are also phagocytic cells, by engulfing and killing pathogens. Eosinophils release 
eosinophils protease, which plays an important role in tissue remodelling and the targeting of 
large parasites that cannot be phagocytosed. Natural Killer (NK) cells have the ability to kill 
tumour cells following the loss of MHC-I, they are known to produce IFN-γ and TNF-α which 
act on macrophages to enhance the immune response. Dendritic cells (DCs) are the major 
antigen-presenting cells (APCs) but also play a role in the degrading of evading pathogens. 
There are different types of DCs, and their location is associated with their function. However, 
their major role remains the linking of the innate immunity and the adaptive immunity, through 
their ability to take and process antigens and migrate to secondary lymphoid organs where they 
present to  T cells to initiate the immune response (Medzhitov & Janeway 2000; Akira et al. 
2006) 
1.1.3 Adaptive Immunity 
 
Activation of the adaptive immunity is orchestrated by the innate immune system when it does 
not successfully eradicate invading pathogen, initiation is typically delayed and but when 
activated, it mounts defences that are specific to the exposed antigens. There is immunological 
memory after exposure to a particular antigen. Adaptive immunity is base on two arms, the 
humoral and cell-mediated immunity. Infected antigen-presenting cells (APC) migrate to the 
lymph nodes to cross-talk with  T cells leading to clonal expansion of antigen-specific T cells. 
At the lymph nodes, CD8+ and CD4+ T cells are activated via MHC-I and MHC-II antigen 
presentations respectively. γδ T-cells and NK T-cells also expand during activation and display 
immune effector functions. Adaptive immunity expresses a large repertoire of genetic 
recombination both in antibodies/immunoglobulins and T cell receptors allowing the 
recognition of a broad spectrum of pathogens and misformed or altered self cells.  
CD8+ T cells have been shown to protect intracellular pathogens like Mtb and Lm against 
intracellular pathogens. Mice lacking MHC-I have been shown to be susceptible to immune 
response to tuberculosis and listeriosis (Finelli et al. 1999; Sousa et al. 2000) with studies in 
humans having a similar effect (Cooper 2009; Bruns et al. 2009) CD8+ T cells play an 
important role most especially against bacteria located in the cytoplasm like Lm. CD8+ T cells 
directly kill infected cells by the release of granules like granzymes and perforin (Kaufmann 
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1993) these cells also indirectly assist in the killing of pathogens by the production of  IFN-γ 
and TNF-α  that recruits macrophages (Ngai et al. 2007). 
CD4+ T cells play a pivotal role in intracellular pathogens located inside the vacuole such as 
Mtb. The role of CD4+ T cells in tuberculosis has been supported by the fact that HIV virus 
induces depletion CD4+ T cells, which are essetial in maintaining latently infected tuberculosis 
patient. Depletion of CD4 T cells leads some of these patients developing active tuberculosis, 
hence the link between these diseases in co-infection settings (Geldmacher et al. 2012).  
CD4+ T cells polarise into different subsets, depending on the antigenic peptides and cytokines 
during infection. These subsets include Th1, Th2, ThFH, Th17 and T reg with an enhanced or 
protective outcome, depending on the immune response. Some of the subsets are discussed 
below. 
Th1 cells are characterised by the presence of the transcription factors T-bet and Signal 
transducer and activator of transcription 4 (STAT4) which are required for their development 
(Szabo et al. 2000; Thieu et al. 2008). Th1 cells develop in response to viruses and intracellular 
pathogen which are essential for clearance. Activation is occastrated, by the secretion of IL-12 
by macrophages which ochastrate the activation of  CD4 T cells to produce IFN-γ. This 
antimicrobial activity is the central effector action of Th1 cells. IFN-γ activates macrophage 
antimicrobial effector pathways like inducible nitric oxide synthase (iNOS), upregulating the 
expression of ROIs and RNIs. IFN-γ also plays a major role for the maturation of phagosome, 
acidification, autophagy and Vitamin D receptor signalling (Chan et al. 1992; MacMicking et 
al. 2003; Gutierrez et al. 2004) Mice lacking INF-γ produced by CD4 T cells have been shown 
to susceptible to Mtb infection. Though other subsets such as NK cells, CD8+ cells, CD1-
restricted, γδ Tcells secrete IFN-γ, CD4+T cells remain the major source. The other subset 
cannot adequately compensate for the production of IFN-γ in the absence of CD4+ cells. 
(O’Garra et al. 2013). Other cytokines critical for the control of intracellular pathogens are IL-
12 and TNF. TNF like IFN-γ is crucial in both humans and mice for immunity to TB (Bean et 
al. 1999), patients on anti-TNF for rheumatic diseases have been shown to have a fivefold risk 
factor to develop active TB (Keane et al. 2001). Though production of such key cytokines by 
Th1 cells does not necessarily translate into protection against disease suggesting other key 
factors are required for the protective interplay. It is, for this reason, the central dogma of IFN-
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γ secretion is neccesarry but not sufficient for protection against Tuberculosis (Nunes-Alves et 
al. 2014). 
Th2 cells are important for extracellular parasites, such as in asthma and allergic diseases. 
Similar to Th1 cells, Th2 differentiate from CD4+ T cells. GATA3 and STAT6 are key 
transcription factors necessary for their differentiation and expression (Zhu 2010). Th2 cells 
release IL-4, IL-5, IL-13, and IL-10 cytokines that suppress or control immune response during 
phagocyte-independent responses. IL-4 receptor alpha chain (IL-4Rα)/STAT6/GATA3 and IL-
2/STAT5 signalling through Th2 cell are vital for Th2 differentiation. Th2 play a role in 
intracellular diseases in damping inflammation or subverting immune killing. IL-4 and IL-13 
have been shown to be upregulated in active Tuberculosis patients with a corresponding 
downregulation of Th1 responses (Seah et al. 2000; Harris et al. 2007). Antigen triggering 
producing key cytokine IL-4 plays a major role in the differentiation of CD4+ naïve T cells, 
and also neutralises macrophage antimicrobial activity by reversing the actions of IFN-γ, and 
GM-CSF (Bhattacharya et al. 2015). 
Th17 T cells have as major transcription factor RORγt and STAT3 that are essential for the 
modulating and balancing of these cells. STAT3 is known to have a pleiotropic function and 
not specific to Th17 cells only, therefore RORγt remains the definding transcritptional factor 
(Durant et al. 2010). Th17 cells arise at the peripheral from the differentiation of CD4+ Naïve T 
cells, induced by IL-23, IL-6 and TGF-β. Their secretion is associated with the defends against 
autoimmune disease, fungi and extracellular bacteria. (Durant et al. 2010) Th17 cells are also 
known to produce IFN-γ during active tuberculosis disease, but a shift in the production of IL-
17 during the active state is known to recruit neutrophils which may be detrimental and causes 
tissue damage during active tuberculosis (Torrado & Cooper 2010). 
T regulatory cells (Tregs) are another very important  Th subset, they express the forkhead box 
P3 (Foxp3) helix as a transcriptional factor. Foxp3 determines the T cell lineage in addition to 
CD4,+ CD25+ under naïve state. CD25+ is not a marker during infection this is so because 
effector T cells also express CD25+ (IL-2Rα), making it difficult to distinguish Tregs without 
the crucial Foxp3 transcriptional factor. The ectopic expression of Foxp3 in other tissues or 
cellular poulation has been shown to perform similar regulatory functions therby confirming 
their expression signify T cell regulatotion (Hori et al. 2003). Mutation of Foxp3 in humans 
leads to the development of multiorgan autoimmune disease, allergy, and immune 
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dysregulation, polyendocrinopathy X -linked (IPEX) syndrome (Zhu et al. 2017) There are two 
subsets of Tregs natural Tregs (nTregs), developing directly from the thymus and inducible 
Tregs (iTregs) which are induced from CD4+ naïve cells at the periphery in response to an 
antigen, TGF-β and IL-2. (La Cava 2008). T regs play a major role to maintain immune 
tolerance to self-antigens by secreting the cytokines TGF-β, IL-10 which have an inhibitory 
effect in response to immune activation during infection. T regs also alter the activation and 
differentiation of antigen-presenting cells thereby delaying the differentiation of CD4+ T cells 
during infection (Bluestone & Tang 2005). 
Though Th1, Th2, Th17 and Tregs discussed above are the major lineages, there are more 
recent subsets like Follicular helper T cells (Tfh) expressing Bcl6 as its transcriptional factor 
that assist B cells in the production of antibodies (Hale & Ahmed 2015). Wide range of 
plasticity has been suggested in different T cells, suggesting differentiation is not terminal and 
subject to differences depending on the circumstances (O’Shea & Paul 2010). Plasticity of the 
tranditional linages are well known, with individual lineages that could produce signature 
cytokines of other subsets under certain condition, for example, IL-10 is produced by Th1, 
Th2, T regs and Th17 cells subsets, though normally secreted by T regs (Veldhoen et al. 2008; 
Saraiva et al. 2009). The understanding of class-switching during infection and the conditions 
influencing these differences are important for theurapuetic purposes. The different subsets can 
also express more than one transcriptional signature with different functions. T regs expressing 
both Foxp3 and RORγt (O’Shea & Paul 2010) under certain conditions, suggesting other 
factors like cellular differentiation, epigenetics can influence the function. Ex-Foxp3 cells have 
been known to acquire the capacity to produce predominantly Th1 cytokines like IFN-γ or IL-
17 for Th17 cells (Xu et al. 2007; Wei et al. 2009; Zhu 2010), and also Th2 cytokines such as 




Figure 1. 2 T Helper cell differentiation according to traditional lineages Differentiation of CD4 T 
cells: Dendritic cell presenting MHC-II loaded antigen to naïve CD4+ T cell, with their master 
transcriptional regulatory factor. These subsets produce certain cytokines as illustrated above but recent 
studies show this cytokine is not limited to fixed linages but there is growing evidence of plasticity 
among different subgroups depending on the pathogen condition. Image source from (O’Shea & Paul 
2010). 
 
Studies on the role of IL-4 on the effect of T regs have been inconclusive.  Addition of IL-4 on 
Th2 cells was shown to reduce the effect of T regs suppression, similarly in another study 
treatment of  Th2 T cells with monoclonal antibody anti-IL-4 led to the depleting of T regs. 
(Cosmi et al. 2004; Tu et al. 2017).In addition, exposure of IL-4 on Tregs prevented apoptosis 
and conserving Foxp3, leading to T reg survival and potency, translating into controlling naïve 
CD4+ T cells (Pace et al. 2005; Maerten et al. 2005) 
1.1.4 Cytokines 
 
Cytokines are small proteins (low molecular weight) including chemokines, interferons, 
interleukins, lymphokines and tumour necrosis factors released by myeloid cells like 
neurophils, macrophages and dendretic cells, T cells CD4 and CD8 during immune activation 
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play a vital for cell signalling. They have pleiotropic effects which include the regulation of 
innate and adaptive immune responses. Their release affects cells around them, leading to the 
recruitment of other cells including neutrophils and macrophages (Vilček & Feldmann 2004). 
Cytokines act in an autocrine manner, affecting the cells that secrete them, paracrine, affecting 
the surrounding cells, or endocrine manner affecting cells away from the area of secretion, 
however, they are very distinct from hormones. Cytokines play a primordial role in the 
differentiation, proliferation of immune cells. (Dempsey et al. 2003). Their responses are 
essential for host survival but are also detrimental in disease if not well controled or regulated. 
For example, IFN-γ is important for defence against intracellular pathogens like Lm and Mtb 
and most autoimmune diseases. Inadequate regulation or excessive secretion has been shown to 
cause tissue damage in viral and bacterial infections (Davidson et al. 2015). Also, IL-2 is 
required for cytotoxic T cells (CTL) generation also required for most vaccines, however, it 
drives graft/host disease and is involved in bone marrow transplantation. (Dinarello 2007)  
There are currently thirty-three interleukins, with the IL-1 family with eleven members 
including IL-1α, IL-β, IL-18, and IL-33, having well-described overlapping functions within 
the family involved in pro-inflammatory secretion. The IL-6 family includes the IL-11, 
leukaemia inhibitory factor, oncostatin ciliary neurotropic factor and cardiotropin-1, members 
activate hepatic acute proteins. The IL-10 family has as member IL-22 which play an important 
role in damping or regulating inflammatory responses. IL-2, IL-7, IL-9, IL-15, IL-21 perform 
similar functions in promoting T cell differentiation into effector T cells and memory T cells 
during immune activation (Liao et al. 2011). The colony stimulation factors (CSF) such as 
granulocyte-CSF, granulocyte-macrophage CSF, have distinct genes and receptors but perform 
overlapping functions in promoting myeloid cell proliferation and maturation. There are 
several types of chemokines, classified into four main groups, they act as a chemoattractant in 






1.2 Listeria monocytogenes 
 
Listeria monocytogenes (Lm) is a gram-positive facultative anaerobic rod-shaped (0.4 by 1-
1.5µm) and are non-spore/capsule forming and no capsule, of low G+C content. It is the cause 
of listeriosis in humans and most mammals. It is a foodborne disease and broadly found in 
Table 1.1 Different types of cytokine their sources, and targeted cells with brief but not limited 
biological functions. 
 Differ nt ypes of cytokine their sources, and targeted cel s ith ri f t le . 1 Di ferent types of cytokine their sources, and targeted cells it  ri f
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nature. The presence of Lm is found on ready to eat foods products (unpasteurized milk, 
cheeses, raw vegetable, ice cream, lunch meats and refrigerated smoked seafood). Infections 
occur when humans consume contaminated food products. Lm is highly tolerant to salt, and 
acidic conditions and can grow, survive at low temperatures. Tracking the source of is 
challenging, this is so because the time frame of infection and the incubation is long. It takes 
from 3 to over 70 days for illness to develop clinical symptoms which include fever, headache, 
muscle aches and non-specific syptoms like chills. Illness can be mild in immunocompetent 
individuals, but high risk individuals like children, pregnant women and the elderly, the 
infection can be lethal. (Ferreira et al. 2014). In certain cases, serious blood infection 
(septicemia) can occur (Figure 1.3), inflammation of the brain (encephalitis), inflammation of 
the spinal cord (miningitis). In mothers with Lm infection, outward symptoms may not appear, 
the fetus might be seriously affected. These individuals are unable to develop adapted and 
redrawn from (Sahibzada et al. 2017) adequate immune response to Lm infection. Lm grows in 
both phagocytic and non-phagocytic cells, easily handled in vitro and grows in tissue cultured 
cells. The immune system clears off the invasion in low doses in immunocompetent 
individuals, however, high doses consumption of food infested with Lm, results in 
gastrointestinal problems. In mouse models, infections and their dynamics are fast, which 





Figure 1. 3 Schematic pathophysiology of Listeria monocytogenes infection, showing some of the main 
organs affected and the effect on immunocompromised individuals, redrawned from (Vázquez-Boland 
et al. 2001) 
 
1.2.1 Listeria monocytogenes  History  
 
Initially, Lm was discovered in the blood of laboratory rabbits and was named Bacterium 
monocytogenes by E.G.D Murray in 1924 since it could not be allocated to any pathogen genus 
at the time (Murray et al. 1926). It was only named L. monocytogenes in 1940 after 
confirmation as a Gram-positive rod by a catalase test (Pirie 1940). It was recognised as a 
significant foodborne pathogen, when a series of outbreaks started occurring in the USA and 
Europe in the 80s, thereafter, there have been other cases described worldwide (Schlech et al. 
1983; Linnan et al. 1988; Miettinen et al. 1999). mortality rates of up to 30% have been 
recorded notwithstanding the availability of many antibiotics to treat Lm (Hamon et al. 2006). 
Lm can cross the blood-brain barrier, the placenta, also infecting organs such as the liver, 
spleen, the blood causing septicemia and minigitis. In South africa, there have been recent ( 
2017 and 2018), large-scale outbreaks, which remains the largest to date (Desai et al. 2019). 
Several outbreaks in recent times with more than 950 confirmed cases, in certain circumstances 
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mortality, reached 27%. These figures are comparable to outbreaks of other food borne 
diseases like E coli and Salmonella, though infectious is less lethal than Lm. (World Health 
Organization (WHO) 2018) 
Lm uses the host machinery to enter various tissues and spread from cell to cell, invading non-
phagocytic cells; like endothelial, epithelial, hepatic and phagocytic cells like macrophages and 
dendritic cells (Pamer 2004) (Figure 1.4). The internalin (lnl) genes lnlA and InlB and p60 are 
used to gain entry into the various cells, once inside, the host surface receptors like E-cadherin, 
mesenchymal-epithelial transition factor (Met) and hepatocyte growth factor (HGF), 
component of extracellular matrix (ECM), and fibronecyin, entry is also facilitated by host 
opsonin-dependent pathway using the Fc gamma receptor (FcγR)/C3bi/C1q complement 
receptor (Edelson & Unanue 2001) In the opsonin-dependent pathway, Lm becomes coated 
with immunoglobulins IgG and C3bi/C1q complements in the bloodstream, which has the 
ability to interact with extracellular matrix proteins like collagens and fibronectin. This anchors 
on the cell wall of the host by IgG and C3bi/C1 and facilitates their uptake (Kwiatkowska & 
Sobota 1999). In the absence of serum, Lm is taken up, an indication of a nonopsonic 
macrophage scavenger receptor-ligand might be involved (Dunne et al. 1994; Greenberg et al. 
1996; Vázquez-Boland et al. 2001). In other pathways (serum independent), surface proteins of 
Lm adhere to extracellular matrix protein containing ∞-D-galactose in dendritic cells, while in 
macrophages it binds to the scavenger receptor leading to entry, through phospholipid 
metabolism of the actin, remodelling of the cytoskeleton and acceleration of membrane traffic 
(Vieira et al. 2002). Following entry inside the cell, most of the Lm pathogen is killed within 
the first hour by phagosome-lysosome fusion, nonetheless, 14% of the bacteria escape into the 
cytoplasm using listeriolysin-O (LLO) (Cossart et al. 1989). Mutations in LLO renders Lm less 
virulent, limiting it into the cell for host killing. In other species like Bacillus subtilis LLO 
expression enables it to escape host vacuole (Stachowiak et al. 2012). Furthermore, purified 
LLO at certain pH dissolves the vacuole, demonstrating an important role of LLO in Lm 
virulence (Bielecki et al. 1990; Lee et al. 2009). Once escaped into the cytosol, the host actin 
protein is hijacked by the bacteria protein ActA for motility. (Figure 1.4) ActA is used to 
spread from cell to cell with the speed of movement determined by the concentration of protein 
actin, cell type, and environment. Lecithinase gene Phosphoryl-choline phospholipase A and B 
(pclA and pclB) are involved in the movements to adjacent cells after secondary invasion 
(Vazquez-Boland et al. 1992). The role of ActA gene was described when mutant Tn917-lac 
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was defective for polymerization in tissue culture, bacteria could escape the vacuole but was 
unable move inside the cytoplasm. ActA gene alone is sufficient to mediate polymerisation-
driven mobility of bacteria (Smith et al. 1995; Kocks et al. 1995) ActA uses the host cell 
machinery for Lm to move inside vacuole, it is responsible for the polymerization of actin tails. 
ActA performs this function mimicking the host actin nucleated factors like Wiskott–Aldrich 
syndrome protein (WASP) comprising Arp2/Arp3 complex, this complex is activated by VCA 
region of WASP. ActA also contain a VCA region which facilitates its capacity to polymerize 
the host actin for its movements .(Pizarro‐Cerdá & Cossart 2006) 
 
Figure 1. 4 Listeria monocytogenes, pathogenesis and cellular infection cellular and secreted proteins 
that enable attachment to the host. Listeriolysin-O (LLO) perforates phagosome membrane and escape 
into the cytosol, movement from cell to cell by the use ActA-dependent tail. Image from (Pamer 2004) 
 
Lm uses InIA/B to subvert its host by avoiding non-phagocytic cells for easy persistence and 
evade immune activation. This enables it to multiply unabated, and secure a relatively safe 
niche (Cossart & Helenius 2014). During entry InIB which contains leucine-rich repeats, binds 
and stimulate the host proteins HGF and Met, leading to activation and proliferation and 
signalling through phosphatidylinositol 3-kinase (PI3K) and Ras-mitogen-activated protein 
kinase (MAPK) pathways eventually leading to entry into the host (Shen et al. 2000). Binding 
of InIB to E-cadherin recruits Arp2/3 complex which functions in creating new actin branches 
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by nucleating new actin filaments. Arp2/3 complex activation is mediated by cortactin 
(Helwani et al. 2004). Cortactin recruits Rac1, a GTPase family member, Lm then triggers 
Rac1, which controls Arp2/3 complex facilitating cortactin translocation to Lm entry sites 
(Sousa et al. 2007). This process is as a result of InIA/B “mimicking’ of homophilic E-adherin 
to initiate the activation of Rac1. InLB has also been shown to mimic the ligand hepatocyte 
growth factor(HGF), Met a tyrosine kinase receptor involved in mediating the proliferation and 
motility (Ferraris et al. 2010) InlA initiates Src-mediated tyrosine phosphorylation of E-
cadherin, leading to ubiquitination by the cbl-like ubiquitin ligases (Bonazzi et al. 2008) which 
recruits clathrin-coated pits, thereby enabling the recruitment of actin. Therefore, InIA/InIB 
takes advantage of E-cadherin and the HGF-met mediated signalling pathways for its entry into 
the host (de Souza Santos & Orth 2015). 
ListeriolysinO (LLO) functions better in an acidic milieu (pH 4.5-6.5), with optimal activity at 
pH5.5, an ideal pH to preserve LLO in the vacuole and enable escape into the cytosol (Glomski 
et al. 2002). Infected cells are protected from LLO in the phagosome and interact with the cell 
membrane and become neutralised with the high pH. This activity of LLO to change according 
to environment and pH, makes it better adapted to hijack and escape the phagosome from 
phagocytic killing. 
ActA uses the host cell machinery for Lm to move inside vacuole, it is responsible for the 
polymerization of actin tails. ActA performs this function mimicking the host actin nucleated 
factors like Wiskott–Aldrich syndrome protein (WASP) comprising Arp2/ Arp3 complex, this 
complex is activated by VCA region of WASP. ActA also contains a VCA region which 
facilitates its capacity to polymerize the host actin for its movements (Pizarro‐Cerdá & Cossart 
2006) Lm has other mechanisms used to hijack and subvert host cellular machinery for entry, 
escape from the phagosome and movement to infect other cells not discussed here.  
1.2.2 Host Killing and immune Responses to Lm 
 
Like most other pathogens, the innate immune response plays a primordial role towards the 
elimination of Lm during initial infection, this role is usually non-specific, and it is the prelude 
for the adaptive immunity in case of insufficient clearance. The major phagocytic cells 
involved are neutrophils, resident macrophages, and natural killer (NK) cells. The role of innate 
immunity has been demonstrated in Severe Combined Immuno deficient (SCID) mice, lacking 
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functional B and T cells, and nude mice, with no adaptive immunity. These mice are able to 
control Lm during the early stages but fail during the adaptive immunity phase (Bancroft et al. 
1991), which is cell-mediated mainly by CD8 T cytotoxic cells lysing Lm (Bancroft et al. 1991; 
Unanue 1997). The liver and spleen are the first immune organs against Lm which are the first 
targets in preventing sepsis and dissemination and clear the pathogen by circulating resident 
macrophages. In the liver, the kupffer cells increase and are bactericidal, depletion of kupffer 
cells has been shown to increase bacilli burdens (Gregory & Wing 2002). Apart from these 
cells, there are some important cytokines and chemokines that are produced by innate cells IL-
1, IFN-γ, IL-6, IL-10 TNF, IL-12, IL-18, MIP-2, (MIP)-1α, MIP-1β that are important for host 
killing of Lm.(Andersson et al. 1998; Brombacher et al. 1999; Lochner et al. 2008; McIlwain et 
al. 2012; Hoge et al. 2013). Resident macrophages do not kill all bacilli by phagolysosome 
fusion, the remaining bacteria in the liver grows in the hepatocytes (Cousens & Wing 2000; 
Zimmerer et al. 2016), Lm enters the parenchyma by two methods; uptake by kupffer cells, and 
by the hepatocytes using InIB and Met receptor (Shen et al. 2000) inhibiting the dead of host 
cell. Neutrophils are the first responder cells in most extracellular bacterial pathogens. During 
Lm, neutrophils are crucial for its control, early depletion of neutrophils using anti-GR1 and 
monoclonal antibody (RB6-8C5) have been shown to be detrimental in the control during 
infection. Though some studies show neutrophils playing no major role. The differences 
observed in different studies might be due to the route of administration of Lm and the target of 
the antibody (Shi et al. 2011). Besides neutrophils, inflammatory monocytes produce IL-12 and 
IL-15, and CCR2+, two to four days after infection, monocytes replace neutrophils and in 
combinations to other cells congregate to form granuloma lesions, which preventing bacteria 
dissemination and eventual spread from cell to cell. NK cells produce IFN-γ necessary for 
macrophage and in combination with IL-6, TNF-α, IL-12 cytokines and inducible nitric oxide 
synthase (iNOS), ROS reactive oxygen (ROS) species which are key for clearance in 
macrophages to kill Lm by phagocytosis (Witter et al. 2016). Failure to adequately clear Lm by 
innate immune cells leads to Lm-specific T cells, activation is required to eliminate the 
bacterial and illicit T cell memory that offers protection during reinfection. T cells recruitment 
peaks from days 5 to 9 (Busch et al. 1998)  CD4+ T cells and CD8+ T cells proliferate and 
differentiate independent of antigen, contribute towards cytokine production. (Mercado et al. 
2000; Wong & Pamer 2001). CD8 T cells are the principal contributor in primary responses 
during Lm infection and most especially in secondary infection for protective immune memory 
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responses (Pope et al. 2001). This has been confirmed by in vivo where depletion of CD8 T 
cells was shown to play a significant role (Czuprynski & Brown 1990; Kaufmann 1993). Lm 
peptides are presented either by major histocompatibility complex (MHC) MHC class I or 
MHC class II depending on the cell degradation of the peptide takes place either in the 
phagosome of the cytosol (Hiltbold & Ziegler 1993) When Lm gets inside the cytosol after 
escape from the vacuole, it is subjected to degradation by the proteasome. The peptides are 
loaded into MHC-I and presented to CD8+ T cells (Wolf & Princiotta 2013). On the other hand, 
CD4+ T cells are presented peptides degraded from the lysosomes and peptides presented by 
MHC-II. Cross presentation also takes place when antigens from the lysosome traffic into the 
endoplasmic reticulum and are loaded to MHC-I (Hiltbold & Ziegler 1993).  CD8 T cells 
potentiate Lm immunity in two mechanisms which are synergistic, CD8 T cells secrete IFN-γ 
perforin and granzymes that lyse Lm infected cells thereby exposing them to macrophage 
targeted killing  (Harty & Badovinac 2002). Pathogenicity of Lm is achieved by its ability to 
escape the phagosome into the cytosol using LLO (Berche et al. 1987). CD4 T cells play a 
lesser role than CD8 T cells during Lm infection. However, production of IFN-γ, TNF and IL-
2, which are known to costimulate CD8 T cells in response to infection. (Shedlock et al. 2003). 
The role of CD4 T cells in Lm infection has been further confirmed by depletion experiments 
leading to susceptibility during infection (Romagnoli et al. 2017). During restimulation, 
memory T cells become activated and proliferate to control and eliminate Lm. This is achieved 
by the IFN-γ secretion by CD4 T cells that activate macrophages (Mouchacca et al. 2015). 
Perforin forms pores and is secreted by CD8 T cells and NK cells, it.is the most effective 
enzyme in clearing Lm during secondary infection (Harty et al. 1996). Mice deficient of 
perforin can control Lm during primary infection however, they succumb after re-challenged 
(Kägi et al. 1994). The function of perforin, granzyme B and other pro-inflammatory cytokines 
are influenced by many factors. Cytokines secreted by T reg are also known to affect cells 
around them and the type of cytokines there produce. Thus, understanding the relationship of T 






 1.2.3 T Regulatory cells and Lm 
 
Regulatory T cells secrete inhibitory cytokine including IL10 and TGF-β to dampen the 
activities of other T cells by immunosuppression. They are defined by the expression of 
CD4+CD25+ and the transcription factor Foxp3 (Hill et al. 2007). The role of T reg during Lm 
is not well studied. In one study, it was shown that during infection, immune expansion of T 
reg plays a detrimental role. This is so because T regs secrete inhibitory cytokines that depend 
on the effect of pro-inflammatory cytokines that are necessary for Th1 responses (Adalid-
Peralta et al. 2011). Transient ablation of T regulatory cells has been shown to favour the rapid 
proliferation of CD8+ T cells, which are necessary for protection against listeriosis (Harty & 
Badovinac 2002). Importantly, during pregnancy, T regs are known to expand up to 50% of 
their initial levels, this expansion is to maintain maternal tolerance to the foetus during 
pregnancy. (Ertelt et al. 2011) However, increase T regs have been shown to be detrimental 
during infection with Lm (Rowe et al. 2011). Transgenically induced T regs were shown to 
cause heightened susceptibility in infected mouse with Lm during pregnancy (Rowe et al. 
2011). Maintenance of Foxp3 cells has been shown to be dose dependent during Lm infection. 
Low dose Lm induces a primary antigen-specific CD8+ cytotoxic response dependent on 
CD4+T cells. High dose Lm response is significantly inhibited by CD4+CD25+FoxP3+ (Treg) 
(Dolina & Schoenberger 2017b). Similarly, the use of an LLO truncated human papillomavirus 
(HPV) based vaccine protein reduces the number of T reg cells (Gunn et al. 2001). Other 
studies show mutant attenuated Lm strain-based vaccine decreases the T reg with a 
corresponding increase in CD4+ Foxp3- T cells, CD8+ T cells by a mechanism dependent on 
LLO (Gunn et al. 2001). These studies suggest that T reg numbers and population affects the 
function of CD4 T cell and CD8+ cytotoxic T cells during Lm infection. In mouse studies, 
transient ablation of Foxp3+ T reg led to a corresponding increase in CD8+ T cells leading to 
the protection during Lm (Rowe et al. 2011). However, this effect was not observed with 
recombinant Lm demonstrating that virulent Lm is required to elucidate protection and activate 
T regulatory cells proliferation (Ertelt et al. 2011). Splenic CD8+ T cells expansion during 
infection leads to the secretion of key cytokines including IFN-γ, TNF and most importantly 
perforin potentiating in the effector killing function during infection. Even though these 
cytokines are also produced by other cells (NK cells and DCs,  Mphs) (Harty & Badovinac 
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2002). CD8+ T cells secrete more perforin than CD4+ T cells that control of Lm growth. 
(Spaner et al. 1999). 
 
    
Figure 1. 5 Diagrammatic representation of macrophage activation and CD8+ T cell, the cytotoxic 
killing of Listeria monocytogenes with the production of IL-12 activation NK cells, CD4+ T cells and 
CD8+ T cells producing IFN-γ for direct killing or Cytotoxic killing by perforin and/or granzyme B.  
 
Lm and Mycobacterium tuberculosis (Mtb) are both intracellular pathogens. Mtb remains one 
of the deadliest infectious pathogens, owing to its mechanism to hijack and evade host immune 
response. Lm has been widely used to understand host immune responses to identify genes 
against intracellular pathogens. Lm evades phagocytic and non-phagocytic cells to multiply and 




Tuberculosis (TB) is caused by Mycobacterium tuberculosis (Mtb) principally by airborne 
route between humans and is one of the greatest public health menaces with human 
immunodeficiency virus (HIV) as the major cause of death due to infectious diseases. There are 
medications for TB, the incidence, prevalence and mortality are still relatively stagnant. 
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Despite much efforts towards the elimination of the disease, TB still remains a major epidemic 
globally. TB mostly affects the poor and vulnerable populations disproportionately due to 
malnutrition, overcrowding and poor ventilation in houses. Current medications to TB are 
limited due to continuous development of drug-resistant forms thereby adding layers of 
complication in the available treatment options. 
1.3.1 Brief History 
 
TB has beset mankind for thousands of years. Mycobacterium ulcerans is thought to be of the 
Jurassic times causing human infections (Hayman 1984).  Early progenitors of Mtb infected 
hominids were reported three million years ago in East Africa (Gutierrez et al. 2005). Early 
Egyptian arts and mummies dating 2400 BC with skeletal deformities and Pott’s lesions that 
similar to Mtb infection (Morse et al. 1964; Zimmerman 1979). The old biblical testament has 
references to TB, during the time the Israelites lived in Egypt in the books of Deuteronomy and 
Leviticus (Daniel & Daniel 1999).  Mortality rates of 900 per 100 000 inhabitants per year 
were recorded in 18th century Europe. In the 19th century, the description of phthisis attributing 
it to TB or a form of cancer as it was known then “cheese-like’’ abscesses (Houston 1999). In 
1810, a French physician described disseminated form of TB known as “miliary” TB (Garrison 
1921).   
Early isolation of TB was cultured on egg white sterile flask, which turns muddy, this was 
recognised as mobile bacilli, which upon inoculation into Guinea pigs caused disease. Robert 
Koch used modern methods of methylene blue staining to identify the bacilli which remain a 
milestone in the fight against TB (Barberis et al. 2017). Charles Mantoux, Esmond R. Long 
and Florence Seibert developed the purified protein derivative (PPD) test base in Robert Koch 
tuberculin reaction (Barberis et al. 2017). In 1951, three research groups identified isoniazid as 
an anti-tuberculosis drug, the following year, Sir John Crofton introduced the use of tri-therapy 
with a combination of streptomycin, para-aminosalicyclic acid and isoniazid. Despite these 






1.3.2 Epidemiology of TB 
 
According to WHO, about 10 million people fell ill due to TB in 2018, with 1.6 million dead as 
a result of the disease, TB is also the primary killer among people with HIV. One Million 
Children develop TB with about 230 000 and died of the disease in the same year. A major 
blow to TB treatment is the emergence of multidrug-resistance (MDR-TB) with 558 000 new 
cases of resistance to rifampicin, which remains the most effective first-line drug treatment. 
Extensive drug resistance is also gaining grounds, defined as extreme drug resistance including 
one fluoroquinolone, and kanamycin, capreomycin and amikacin. Though the incidence of TB 
is dropping globally at 2% per year, the milestone target of 4-5% by 2020 is still farfetched. 
Most of the mortality due to TB occurs in developing countries, India, Russia, Ukraine, the 
Philippines, and China accounts for more than 40%. Tobacco consumption and HIV are a 
major risk factor to increase the risk of active TB (WHO 2018). 
 
Figure 1. 6 Representation of TB high-burden countries: Nigeria, South Africa and DR Congo being 





1.3.3 Immunopathology of TB 
 
TB is transmitted mostly by droplets that contain the bacteria from people to people. The 
human immune system can, in most cases control the infection but does not lead to 
sterilization, these individuals are asymptomatic and are referred to as latently infected 
individuals (Horsburgh & Rubin 2011). These individuals are estimated to represent one-third 
of the global population, which might represent a potential reservoir. Also, 5-10% of these 
individuals subsequently develop TB in their lifetime. Resident lung alveolar macrophages are 
among the first cells for the immune defence, recruitment of other innate immune cells can lead 
to clearance, though this mechanism is not well (Cooper et al. 2011). Macrophages and their 
environmental factors determine the outcome of infection. The ability of macrophages to 
display plasticity and flexibility is important for the immune killing function. Macrophages 
transcription and function to a classical or alternative activation depending on the stimuli, 
during Mtb infection. Classical activation is activated with the release of pro-inflammatory 
cytokines like TNF, IL-12 and IL-1β, which requires control by alternative cytokine release 
necessary for wound healing (Mosser & Edwards 2008) In humans, alveolar macrophages do 
not meet this dichotomy during steady-state, they are ‘hoovering’ for cellular debris and ready 
for pro-inflammatory response during invasion (Hussell & Bell 2014). In non-human primate, a 
collection of cells immune cells during Mtb infection known as granuloma function differently. 
Balancing of classical and alternative activated macrophages is essential for the success of 
granuloma, with alternative activation playing a role in dampening inflammation but in the 
process also inhibit effective bacteria-killing (Flynn et al. 2011). Cytokines play a major role in 
the outcome of Mtb infection, there has an interplay with the induction of the adaptive arm and 
the “cross-talking” at the draining lymph nodes. Cytokines produced during the early stages of 
the disease also enables the initial formation of aggregates of innate cells, and later specialised 
cell types forming granuloma which are the hallmark of TB, these cells include T cells, B cells, 
neutrophils, NK cells, epithelioid macrophages, macrophages, foam cell, dendritic cell, and 
giant cells (Ndlovu & Marakalala 2016). The sequential accumulation of specialized cells 
determines the outcome of infection. Their nature and structure determine the release of 
cytokines and chemokines by activated macrophages in the granuloma (Flynn et al. 2011). 
Monocytes are also recruited from the bloodstream to the lungs and further differentiation into 
macrophages. Dendritic cells arrive as professional antigen presenters picking up Mtb antigens 
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for or dead cells that have been phagocytised or dying cells by efferocytosis. This initial phase 
might lead to the control of Mtb by the innate immunity with negative tuberculin skin test 
(TST) or interferon-gamma release assay (IGRA) results, after repeated exposure to Mtb. The 
adaptive immune arm is activated by the priming from dendritic cells leading to T cell 
differentiation and proliferation. CD4+ T cells play a key role by producing IFN-γ, IL-2, and 
TNF cytokines in response to Mtb infection. Other important cells are CD8+ T cells, Th-17 
cells, B cells and other non-canonical T cells (CD1 restrictive T cells, iNKT cells, γδ T cells, 
Mucosal associated invariant T cells) though not indispensable plays appreciated role in TB 
control (Kaufmann 2002; Nunes-Alves et al. 2014). The adaptive immunity leads to strong 
memory response by T cells with a positive TST and IGRA test. Some patients would be 
positive in TST and IGRA with no clinical symptoms referred to as subclinical TB but will be 
positive for culture, whereas active pulmonary patients will develop clinical symptoms 
including cough, fever, weight loss and will be TST, IGRA positive, culture-positive, sputum 
smear-positive or negative (Pai et al. 2016).  
The T cell population and their plasticity can be exploited for host directed therapy. The IL-
4Rα is a canonical receptor that defines Th2 disease response, through interaction with its 
ligand IL-4 and IL-13. The role of IL-4Rα and TB has not been widely studied. 
1.3.4 Interleukin 4 Receptor alpha (IL-4Rα) and TB 
 
The role of IL-4Rα and IL-4 in TB pathogenesis is contentious with opposing literature on the 
effect on granuloma and advancement to TB both in humans and mice studies.  IL4 and IL-13 
both signal through the IL-4Rα receptor, using the STAT-6 signalling, which is critical for the 
signalling and differentiation of naïve T cells into Th2 and secretion of IL-13/IL-4 (Wills-Karp 
& Finkelman 2008). Mouse model studies with global knockout of IL-4 on a C57BL/6 
background, when infected with BCG, demonstrated that IL-4 was not decisive with no 
differences in bacterial burden and histopathology (Murray & Young 1999). Similarly, Mice 
deficient with the IL-4Rα in C57BL/6 mice also showed comparable bacterial load during Mtb 
infection (North 1998). This suggests that IL-4Rα in C57BL/6 background is not indispensable 
during Mtb infection. However, in BALB/c mice, one study showed no differences in bacteria 
burden when STAT-6 was deleted to skew the Th1/Th2 balance towards a Th1, despite the, 
increase in host protective IL-12, IFN-γ and iNOS, which likely contributed in 
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histopathological differences. This study further showed that IL-4Rα-/- and IL-4/IL-13-/- mice 
had similar growth of Mtb in the lungs, liver and spleen (Jung et al. 2002). Previously, our 
laboratory demonstrated that specific deletion of IL-4Rα on macrophages/neutrophils 
(LysMcreIL-4Rα-/lox) in mice resulted in comparable mortality, bacterial burden, histopathology 
and no differences in iNOS and Arginase (Arg1) following infection with hyper virulent 
HN878 strain of Mtb (Guler et al. 2015).  
 Other studies using a neutralising anti-IL-4 polyclonal or monoclonal antibody in BALB/C 
mice showed differences with decreased CFUs in tissues when anti IL-4 and anti-IL-13 was 
used (Buccheri et al. 2007) A possible explanation in these differences might be a 
compensation mechanism or lack of proper development in IL-4/IL-4Rα mice. Mice with 
transient deletion, therefore, was better suitable in this case (Roy et al. 2008). In BALB/C 
mice, IL-4 had a modestly harmful effect on the Th1 immune response with increased TNF and 
fibrosis (Hernandez-Pando et al. 2004). In asthma models of mice and, IL-4 inhibition using 
monoclonal antibody led to rapid clearance of Mtb (Hart et al. 2002).  Pre-existing 
Nippostrongylus brasiliensis (Nb) (predispose animals to Th2 immune responses) infection, 
shows impaired resistance to Mtb infection in mouse, suggesting a link where TB and 
helminthic infections coexist. Co-infected mice with deletion IL-4Rα-/- and Nb infection 
displayed better ability to control Mtb infection (Potian et al. 2011). In humans, increase lung 
cavity granuloma has been shown to be related to increased expression of IL-4 during the 
progression of the disease (van Crevel et al. 2000). Also, mRNA transcriptional expression of  
IL-4  increases during active pulmonary TB in the lungs (Dheda et al. 2007). Another study 
showed an increase in IL-4Rα mRNA expression in PBMCs (Schauf et al. 1993). A house 
contact study of individuals in contact with active TB patients validated the association of IL-
4/IL-4Rα and TB patient with increase expression of IL-4Rα in both groups upon contact 
(Mihret et al. 2013). IL-4 and IL-13 are structurally and functional similar cytokines, much has 
been studied on IL-4/IL-4Rα but not IL-13 and TB.  IL-13 over-expression  in BALB/c 
background after infection with H37RV strain resulted  in significant increase in(Heitmann et 
al. 2014) pulmonary granulomas. suggest that IL-4/IL-4Rα might be associated with active 







 1.3.5 Foxp3 T regulatory cells and TB 
 
Mtb establishes persistent infections that may require mechanisms that check excessive 
immunological responses. T reg plays a vital role in preventing autoimmunity, but also 
suppress antimicrobial immune responses. Understanding the role of Foxp3 T regs in TB only 
started in 2006 (Guyot-Revol et al. 2006; Quinn et al. 2006). The role of T reg has been studied 
in other models including Leishmania major where they play a role in inhibiting immune 
response during mouse infection. Depletion was shown to enhance clearance with increased 
effector T cell function CD4+CD25- (Belkaid et al. 2002). Mtb is slow in activating the 
adaptive immunity compared to other pathogens, with infected individuals becoming positive 
from 6 weeks onwards (Wallgren 1948; Behr et al. 2018). In mouse models, this delay has 
been observed especially with the recruitment of T cells. (Urdahl et al. 2011). In normal 
circumstances, the early arrival of T cells is associated with clearance of Mtb in the lungs. This 
delay occurs at different phases, which includes, Mtb-infected DCs arrival in the draining 
lymph nodes, delay in effector expansion and migration to the lungs (Chackerian et al. 2002; 
Wolf et al. 2007, 2008; Reiley et al. 2008). In humans during the first weeks of infection, T reg 
is recruited to the lungs corroborated with a decrease in peripheral blood T reg cells (Burl et al. 
2007). This was further confirmed in macaques as T reg was observed to migrate to the lungs 
during early infection (Green et al. 2010). Since we observe a delay in the arrival of CD4+ T 
cells, and the early arrival of T regs, the role of T reg is detrimental during Mtb infection. We 
hypothesis that manipulation of T reg may affect the functionality and quality of T regs, 
thereby influencing the CD4+ T cell effector balance. To achieve this, our laboratory generated 
mice lacking IL-4Rα specifically on Foxp3 T reg.  
 
1.4 Generation of Foxp3+ T regulatory cell-Specific IL-4Rα Knockout mice 
 
The use of cell-specific knockout mice has been a very valuable tool in delineating the function 
of IL-4Rα signalling on various immune cells in different disease models. This has been 
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achieved largely due to the novel methods of using the Cyclization (Cre) recombinase and 
LoxP (locus of X over P). IL-4Rα gene is flanked and either inverted or translocated using the 
enzyme Cre recombinase. The Cre is under the control of a specific cell type, in this case, 
Foxp3 promoter. These mice are crossed with IL-4Rα is flanked by lox-P transgenic mice. The 
offspring of these mice will have a deletion of the specific gene under this promoter by the Cre 
slicing at the lox-P sites. Using this technology, we have in the past generated a transgenic 
mouse that the exons 7 and 9 of the IL-4Rα flanked by the lox-P sites. IL-4Rα deletion of CD4 
T cells (Leeto et al. 2006; Radwanska et al. 2007; Dewals et al. 2009) on B Cells (Hoving et 
al. 2012) on macrophages and neutrophils (Cao et al. 2007) Dendritic cells and alveolar 
macrophages (Hurdayal et al. 2013) and smooth muscle cells (Marillier et al. 2010). In order to 
understand the role of IL-4Rα signalling on key regulatory immune cells, T regs we generated 
IL-4Rα deletion on Foxp3 cells, with an intact receptor on all other immune cell populations. 
 
1.5 Rationale  
 
T-regulatory cells (Treg) have as main function the maintenance of self-tolerance and 
prevention of autoimmunity. However, they also play a crucial role in the homeostatic immune 
response due to pathogenic infection through regulation of inflammation (Smigiel et al. 2014). 
T reg is developed either from the thymus or from the periphery. Thymic T reg migrates to 
secondary lymphoid organs and tissues where they affect cytokines, expand and control tissue 
damage. The ability of T cells to differentiate to different types of lineages and their cytokine 
produced has been highly exploited for their therapeutic potential during infection or 
immunization through their manipulations (Parida et al. 2015) T reg cells (CD25+CD4+ ) have 
been shown to have diverse functions during ablation with different disease models. During L. 
major infection, for example, T reg accumulates within chronic sites of the skin with 
detrimental effects where they suppress effector cells by both IL-10-dependent and 
independent mechanisms (Belkaid et al. 2002). In parasitic infection of Plasmodium berghei, 
Foxp3+ proliferation leads to protection in severe forms of malaria disease, demonstrating a 
beneficiary role (Haque et al. 2010). 
 During viral infection like in herpes simplex depletion of cell specific T reg cells led to 
enhanced CD8+ T cell function; with proliferation and cytotoxicity (Suvas et al. 2003). Studies, 
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where T regs have been depleted with the rebust transcriptional factor signature foxp3 rather 
than CD4+CD25+, have shown conflicting outcome in viruses, parasites, fungi, and bacteria. In 
herpes simplex virus 2, West Nile virus, lymphocytic choriomeningitis virus, Foxp3+ cell 
ablation lead to increased viral load and subsequent mortality (Lund et al. 2008; Lanteri et al. 
2009).  
Similarly, during fungal infection with Candida albicans, adoptive transfer of Foxp3+ Tregs 
into Rag deficient mouse (mice with no T and B cells) led protection compared to mouse 
receiving conventional T cells (CD4+CD25-CD44-) (Pandiyan et al. 2011).  
Paradoxically, in most bacterial infections notable Salmonella enterica,  expansion of Foxp3+ 
Tregs was found to be detrimental during pregnancy and increased bacterial burden (Johanns et 
al. 2010; Rowe et al. 2011). This outcome was similar in Mycobacterium tuberculosis infection 
in which decrease of Foxp3+ cells in mixed chimera mice led to a decreased bacterial burden, 
transfer of Foxp3+ cells reduced the effector's arm and hence decreased killing and subsequent 
more bacterial burden (Scott-Browne et al. 2007; Shafiani et al. 2010). Similarly, in Lm 
infection, Foxp3 cell proliferation resulted in exacerbated bacterial burden due to dampening of 
the effector T cells, is was overturned by Foxp3+ cell deletion  (Rowe et al. 2011).  
Considering the important role T regs play in maintaining immune tolerance, specific 
manipulation of this population in response to molecular cues such as cytokines and cofactors 
has been a promising approach for treatment for communicable and non-communicable 
diseases (Sawant et al. 2012; Jin et al. 2013; Ulges et al. 2015). This can be achieved by 
cytokines, that have reportedly played a critical role in the functions of T reg. Interferon-γ 
(IFN-γ) secretion, Foxp3 T reg cells upregulates the Th1 specific transcriptional factor T-bet 
(Koch et al. 2009) Other cytokines like IL-2 shut down T regs contributing to a Th1 
environment,  TGF-beta and IL-6 driving the expression of Foxp3+ T reg (Bettelli et al. 2007; 
Campbell & Koch 2011). Th2 cytokines have also been shown to play a role in the 
development and function of T reg cells IL-4 through the STAT-6/GATA-3 expression leading 
to decreased levels of T reg converting to a Th2 during type 2 diseases (Wang et al. 2010; 
Hansmann et al. 2012). IL-4 signals through  IL-4 receptor alpha (IL-4Rα) during type 2 
diseases, deleting this specific receptor signalling on Foxp3+ T reg cells, might shift the 
Tregs/Th2 balance to an effector Th1. Methodical increase of IL-4Rα signalling on T regs 
showed reprogrammation into Th2 lineage (susceptible) while deletion led to protection during 
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food allergy (Noval Rivas et al. 2015). In a recent study, a mutation on IL-4Rα on Tregs cells 
led to a Th-17 lineage (Massoud et al. 2016). The role of IL-4Rα on CD4+Foxp3+ regulatory T 
cells was further demonstrated during H polygyrus a Th2 model. IL-4 signalling through IL-
4Rα was required to control H polygyrus, by the convertion of T regs to Th2 cells (Pelly et al. 
2017). Therefore, during infection, since Th2 are essential for the control of H. polygyrus IL-
4Rα presence on T reg is an important component for plasticity to occur. Recently our 
laboratory, reported the role of specific deletion of IL-4Rα on Foxp3 regulatory cells in S. 
mansoni infection  Obliteration led to exercebated tissue damage and excessive inflammation 
at the liver, due to disfunction of the Foxp3+ Treg cells accompanied by uncontrolled effector T 
cells (Aziz et al. 2018). In addition, we have found that IL-4Rα signalling on Foxp3 T reg is 
necessary for the control of allergic responses during House dust mite allergen (in revision). 
These studies highlighted the role of IL-4Rα in Th2 models. The effect of the IL-4Rα in Th1 
models has not been well elucidated. In this study, our aim was to determine the effect of IL-
4Rαdeletion on Foxp3+ T reg cell in T helper 1 (Th1) infecction models. Therefore, the aim of 
this study was to understand the impact of this receptor signalling in driving the outcome of 




We hypothesized that specific deletion of IL-4Rα on FoxP3+ T Regulatory cells affects the 
quality FoxP3+ T Regulatory cells hence rendering them prone to enhanced Th1 effector 
response in mouse model of listeriosis and tuberculosis 
1.5.2 Objectives of this study 
 
(A) To determine the effect of specific deletion of IL-4Rα on FoxP3+ Tregs on the immune 
regulation during Listeria monocytogenes infection in mice 
(B)  To determine the effect of IL-4Rα signalling on FoxP3+ Tregs during Mycobacterium 































2.1 Mouse strain 
 
Deletion of il-4rα gene in Foxp3-expressing cells (Foxp3cre IL-4Rα−/lox) BALB/c mice were 
generated as previsouly described (Aziz et al. 2018). Briefly, Foxp3creIL-4Rα−/lox was produced 
by crossing a Cre BALB/c mice with foxp3 gene promoter and IL-4Rα -/- BALB/C mice for two 
generations and then further crossed with floxed IL-4Rα (IL-4Rα-/lox) BALB/c mice to 
specifically delete IL-4Rα exons 7 and 9 on flanked sites of Foxp3+ T reg. Mice were housed in 
the specific-pathogen free (SPF) animal facility of Faculty of Health Sciences, University of 
Cape Town. 
2.2 Ethics Statement 
 
All experiments with animals and protocols were performed in strict accordance with the South 
African National Standards, as well as the Animal Research Ethics Committee (AEC No. 
015/037 for Listeria and 015/040 for Mtb) of the Faculty of Health Sciences, University of 
Cape Town project. Considerations for the humane ending of the sick mouse was highly 
respected and adhered during the course of the study by all involved in the project.  
2.3 Listeria monocytogenes culture and infection 
 
Stock solutions of Lm (virulent EGD strain) were maintained by mouse passaged in BALB/c 
mouse and grown in a medium of Tryptic‐Soy Broth (TSA)(Difco) at 37o C and harvested at a 
mid-log phase of (O.D600=0.3‐0.6). Harvested Lm was stored in glycerol (%) stocks, at -80°C 
for further use. To determine the stock concentration, serial dilutions were plated on Tryptic 
soy agar (TSA) plates for 24 hours (Dai et al. 1997). During each experiment, the 
concentration was determined by platting before and after infection on a TSA plate at 10-fold 
dilutions. For mortality infections, 2x105 Lm/200µl was used and 2x104 Lm/200µl  for time 
course experiments at 3 and 7 days post infections (dpi).  Foxp3creIL-4Rα−/lox  and littermate 
controls where vaccinated with low Lm (1x104 ) and re-challenged with 100 fold dose 30 days 
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after. All Lm infections were done intra-peritoneally in 200µl volume of PBS using 1ml insulin 
syringe. 
2.4 Mycobacterium tuberculosis culture and infection 
 
Mtb strain H37Rv was BALB/c passaged to maintain virulence and aerosol inhalation 
mimicking the natural route of Mtb infection. Few colonies where picked and grown on a  
7H10 Middlebrook broth (Difco-Detroit-MI, USA) with the addition of Middlebrook OADC 
enrichment medium (Sigma-Aldrich Darmstadt, Germany). A total of 2x106 live bacteria was 
suspended in 6ml PBS solution to obtain a low dose of 100 CFU/lung upon arerosol passage 
using the glass-col nebulising aerosol inhalation system at the BSL3 Animal Facility Unit. The 
dose was confirmed a day later by plating 250µl on 7H10 Middlebrook plates prepared with 
PANTA (polymixin B, amphotericin, nystatin, trimethoprim, azlocillin). (PANTA; Becton, 
Dickinson and Company, Spark, USA) 
2.5 Mouse monitoring after infection 
 
After infection, mice were monitored twice daily for Lm infection and once daily for Mtb-
infected mice. Mice that had lost more than 20% of their initial body weight or presented with 
a severe illness accompanied and/or behavioural changes like hunched back posturing, lack of 
grooming where declared moribund and euthanized. 
2.6 Bacterial burden determination 
 
For both Lm and Mtb infections, bacterial load were determined at various time points. Organs 
were collected in an aseptic manner and divided into three portions (Bacterial burden, histology 
and FACS). Every organ was weight accordingly to determine the propotional bacterial burden 
per organ.  Tissue portions were homogenised in 1X PBS with 0.05% Tween-80. Homogenates 
were serially diluted in a 10-fold in 1X-PBS and 100µl plated in TSA plates for Lm and on 
7H10 agar plates for Mtb. Plates were incubated for 37oC for 24hours (Lm) and 17-21 days for 
Mtb colony counting. 




For each experiment, consistent portions of spleen or lobes of the liver were collected for Lm 
and lungs for Mtb infection. Fixed with 4% formalin and rehydrated with Xylol and alcohol 
during the preparation of slides. Three different cuts ( 2-3µm) were obtained in each mouse for 
hemotoxylin and eosin ( H&E) staining for pathological and immune cell infiltration and lesion 
sizes. The acquisition was done using the Nikon Eclipse 90i Microscope. Analysis and 
visualization of alveolar air spaces were determined using the software Nikon NIS element. 
2.8 Enzyme-linked immunosorbent Assay (ELISA) 
 
Concentrations of the various cytokine and chemokines (IL-12p40, IL-12p70, IL-23, IL-6, 
TNF, IL-1α, IL-1β, IFN-γ, IFN-β, IL-17, Igf-1, IL-10, IL-4, TGF-β, GM-CSF, M-CSF, CCL2, 
CCL3, CXCL1, CXCL10, CXCL2 and CXCL5) were carried out by ELISA. Liver 
homogenates, spleen re-stimulation, and serum for Lm; lung homogenates samples for Mtb 
infection. Sandwiched ELISA was performed on Nunc Maxisorp flat-bottom 96 well plates 
(Roskilde, Denmark) coated with the various antibodies and blocking with 2% BSA. 
Biotinylated detection of secondary antibodies where used according to their cytokines to be 
detected. Horseradish peroxidase (HRP) or alkaline phosphatase (AP) with PNP (4-nitrophenyl 
disodium salt-hexahydrate) (dilution: 0.05g in 50ml ) substrate solution (Sigma Aldrich) was 
used. H2SO4 at 1M was used to stop the reaction. An absorbance of 405 nm was used on the 
SoftMax program.  
2.9 Nitric Oxide Measurement  
 
Lung supernatants were used to measure the concentration of Nitric Oxide (NO) by Griess 
reaction assay. Standards (Na2NO3, 2mM) were prepared at a starting concentration of 0.1M 
with a two-fold serial dilution in triplicates on NUNC flat bottom 96 well plate. 50µL of 
samples were added followed by adding of 25µL reagent A (1% sulfanilamide(C6H8N2O2S) in 
2.5% phosphoric acid (H3PO4) incubated for 5 mins at room temperature and then 25µL 
reagent B (0.1% napthyl ethylenediamine in 2.5% phosphoric acid). Further, incubated in the 
dark for 5-10 mins. When a purple colour was visible relative to the standards the reaction was 
stopped with 100µL of 96% H2SO4/85% H3PO4 /85% H20. Plates were read at 540 nm with 
reference of 690 nm. 
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2.10 Isolation and stimulation of mediastinal lymph node  
 
The mediastinal lymph node was harvested from mice and passed through a 70µM followed by 
40µM strainer to obtain single-cell suspensions. Cells were centrifuged at 1200 rpm for 10 
mins at 4o C. Single cells were resuspended in 2ml complete Dulbecco's Modified Eagle's 
Medium (DMEM, Gibco) supplemented with 10% FCS, viable cells were counted with Trypan 
Blue (0.4%). A total of 2×106 cells were seeded in 100µl media and left unstimulated, or 
stimulated with H37Rv Lysate at 10µg/ml, or 50ng/ml PMA, 250 ng/ml ionomycin combined 
with 200 μM monensin, for 8 hours. Immuno-staining was done with 50μl antibody mix with 
2% rat serum and 10µg FcγRI 
2.11 Real-Time PCR 
 
Total RNA was extracted with mini-elute columns according to the manufacturer’s protocol. 
(Qiagen, http://www.quiagen.com) from splenocyte and hepatocytes after infection at different 
time points. RNA quality was determined using NanoDrop 200. cDNA was obtained by 
transcription using first stranded cDNA Synthesis Kit (Roche). The random hexamer primer 
and anchored oligo dT primers were used with respect to the manufacturer's instructions 
Quantitative Real-time PCR was done with LightCycler® 480 SYBR Green I Master mix in 
LightCycler® 480 II (Roche). HPRT was used as the normalization gene for absolute 
quantifications (Silver et al. 2008). 
2.12 Data extracted from public available transcriptomic studies 
 
Public available cohort studies (Mahomed et al. 2011; Thompson et al. 2017) RNA data was 
obtained from the blood of quantiferon negative (healthy), latently and tuberculosis patients. 
Transcriptional signatures from prospective cohorts data of active TB cases controlled BCG+ 
cases were plotted from South Africa, (Malawi and united Kingdom) (Maerten et al. 2005; 
Berry et al. 2010; Mahomed et al. 2011; Bloom et al. 2013; Cliff et al. 2013; Kaforou et al. 
2013; Dawany et al. 2014; Zhai et al. 2015; Thompson et al. 2017). Latent TB was defined by 
the tuberculin skin test or QuantiFERON Gold test. Active TB was defined as two or more 






2.13 Primers used for murine cell population 
 
 Primers for quantitative RT-PCR of IL-4Rα and Foxp3
Gene Target Primer
FoxP3- Forward 5'-CTGCCACCTGGGATCAATGT-3'
FoxP3- Reverse 5'- GGCAGAGCCCTTCCGCACTT-3'
IL-4Rα-Forward 5'-ACTGGATCTGGGAGCATAAA-3'
IL-4Rα-Reverse 5'-CCTATTCATTTCCATGTGGCA-3'
HPRT – Forward 5'-GGCCATGAGGCTGGATCTC-3'
HPRT -Reverse 5'-AACATTTGAATCCTGCAGCCA-3'  
2.14 Flow Cytometry 
 
Extracellular staining was perfomed on cell population by seeding  2×106 cells per well in a 96 
well NUNC plate in FACS buffer. Centrifuged at 1200 rpm for 5 mins at 4° C. Stained with 
50µL of antibody cocktail [Myeloid panel, CD11C-FITC (clone:HL3), Gr-1-
APCcy7(Clone:RB6-8C5) MHCII-APC(Clone:M5/114.15.2), F4/80Pecy7 (Clone:BM8)] 
[Lyphmphocyte panel CD3-A700 (clone500A2) CD8-V500(S3-6.7)) CD44-FITC (cloneIM7), 
CD62L-V4509 (clone MEL-14), CD19-APCCy7(cloneID3),CD4-Percp (cloneRM4-5),CD124-
PE (cloneG077F6)]. 1% of heat-inactivated rat serum and 10 µg/ml anti-FcR blocking FcγII 
and FcγIII receptors was added. Incubated for 30-35 minutes at 4°C, and resuspended in FACS 
buffer. Further spun down and fixed with 2% paraformaldehyde in PBS, and resuspended in 
200µL of FACS buffer for acquisition. Surface makers of myeloid cells and T cells were 
acquired using the  BD LSRFortessaTM. 
Intra-cellular(IC) cytokine staining was carried out by first surface staining, then washed with 
FACS buffer, centrifuged at 1200 rpm for 5 mins and permeabilised with permeabilisation 
buffer (Invitrogen Life Technologies), for 45-60 minutes in the dark at 4oC. Staining was done 
in 50 µl cytokine Ab cocktail (Ab against different cytokines + (1x 2%iRBS+ 1% 4.2G2)). 
Intracellular cytokines were stained with IL-2-FITC (cloneJES6-5H4), IFNγ-A700 
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(cloneXMG1.2), IL-17-PercyCy5.5 (cloneEbIO17b7), IL-4-PE( clone 11B11), IL-10 (clone 
JES052A5). 
Intra-nuclear(IN) staining was performed similarly to IC, briefly after extracellular staining, 
cells were conditioned with Fixation- Permeabilization wash buffer. Permeabilised by 
incubating for 1hr at 4oC using permeabilization buffer for, FoxP3-APC (cloneMF23), Ki67-
PE (cloneB56), BCL-2FITC (clone3F11), Caspace3-PE (Clone C92-605), GranzymeB V450 
(cloneGB11) , GATA3-Percy (Clone TWAJ). 
The acquisition was achieved using the LSRFortessa™ (BD Immunocytometry Systems, San 
Jose, CA, USA). All generated data from the Fortessa were analysed using Flowjo software 
(FlowJo v10.0.7) (Treestar, Ashland, OR, USA). See gating strategy at the supplementary 
figures. 
2.15 In vitro macrophage coculture with CD4+CD25- and CD4+CD25+ 
2.15.1 Bone marrow-derrived macrophage generation (BMDM) 
 
Bone marrow-derrived macrophage (BMDM) were generated as described previously 
(Hölscher et al. 2006). Briefly, femurs were obtained from 8-12 weeks old male  IL-4Rα-/lox 
BALB/c mice cultured for 10 days with L929-cell conditioned medium. L929-cells was a 
source of granulocyte and macrophage colony stimulating factor with DMEM supplemented 
with 10% fetal calf serum, 5% inactivated horse serum, 1% β-mercaptoethanol, 1mM sodium 
pyruvate, 1% 100U/ml penecillin, 100μg/ml streptomycin (Penstrep), and  2mM L‐glutamine. ( 
Gibco cat 12657-029). After 10 days, cells differentiation were confirmed by microscopy by 
their elongated morphological structure. Debris and non-adherence cells where washed with 
1X PBS. The adherent cells were incubated with 1X PBS containing 5 mM EDTA and 4 mg/ml 
lidocaine for 10 mins. Cells were stained with Trypan blue to distinguish between dead and 
live cells and counted under a microscope using the NebHaur chamber. 25x105 cell/well was 
seeded on a round bottom plate for T cell co-culture. 
 




Seeded BMDMs cells were left overnight and infected with heat killed Lm (HKLM) at a 
multiplicity of infection (MOI) of 1:5 and incubated for 24 hours on CO2 incubator for 24 
hours at 370C.  
2.15.3 Flow cytometry and FACS T cell sorting 
 
Spleens were harvested from FoxP3creIL-4Rα -/lox mice and littermate control mice. Single cell 
suspension to obtain splenocytes was achieved by disrupting spleens through a 40µm filter. 
Washed with DMEM+10% FCS. The cells were counted on the NebHauer Chamber using a 
brightfield microscope (Nikon Ecclipse). T cells sorting was performed using using BD 
FACSAria™ Fusion flow cytometer. FACS analysis was performed using BD LSRFortessaTM 
flow cytometer. Viable cells were determined using LIVE/DEAD BV605 (Thermofisher 
Scientific). Cells stained for CD3-A700, CD4-BV510, CD19-PerCp, and CD25-PE where used 
to obtain CD4+CD25- and CD4+CD25+  cell population. Stained cells were fixed in 2% 
formaldehyde fro 30 minutes at 4oC.  
2.15.4 BMDM co-culture of with T cells 
 
CD4+CD25- (effector) and CD4+CD25+ (T reg) T-cells were added to BMDMs (MØ) in a 48 
well plate at different ratios [ 1 (MØ):1 (effector)  / 1(MØ): 3 (effector)  / 1(MØ): 3 (effector) : 
1(T reg)]. Cells were incubated for 72 hours (3 days). After incubation, the supernatant was 
collected for cytokine ELISAs. Cells were lifted with 1X PBS in EDTA and lidocaine, washed 
and stained. Cells were stained extracllularly with CD4-BV510, CD62L-V450, CD44-FITC, 




All Data was analysed using Prism software (Prism software; http://www.prism-software.com). 
Using either Student’s t-test ( two-tailed with unequal variance) or 1-way-ANOVA Dunnett’s -
post-test. Results are represented as mean ± SD. With statistical significant represented as (*, p 




























The aim of this study is to investigate the role of IL-4Rα on Foxp3 T regulatory cells during 
Listeria monocytogenes and Mycobacterium tuberculosis infections in mice. In this chapter, the 
results are presented in two sections. The first section describes infection with Lm, evaluating 
the differences in the protein levels of both Foxp3 and IL-4Rα, bacterial burden, mortality, 
cytokine dynamics at various tissues, histopathology and immune cell populations that are 
affected due to the loss of IL-4Rα on Foxp3+ T regulatory cells. In the second section of the 
results, we infected mice with Mtb H37Rv strain infection to further understand the role IL-
4Rα signalling plays during slow-growing bacteria infection in mouse models.  
3.1 Section one  
3.1.1 Abstract Lm infection 
  
IL-4Rα signalling on Foxp3+ regulatory T cells regulates immune response to Listeria 
monocytogenes infection 
Cytokine signalling is a significant component influencing the control and function of 
Forkhead box P3 (Foxp3) CD4+CD25+ T regulatory cells (T reg), which are critical in the 
maintenance of self-tolerance, immune homeostasis and regulation of the immune system. IL-
4Rα is the predominant canonical receptor through which IL-4 and IL-13 signals. Th2 
dependent models utilize IL-4Rα signalling on the different cell populations. IL-4 responsive T 
regulatory cells signal through IL-4 Receptor alpha (IL-4Rα) has been widely studied in Th2 
disease models. T regulatory cells are an integral immune cell population that suppresses 
overtly secreted cytokines during inflammation; however, this role can be detrimental during 
bacterial infections by suppressing Th1 responses needed for clearance. Specific manipulation 
of T regs by the deletion of IL-4Rα is a novel approach for Th1 disease settings. There is 
limited knowledge of IL-4Rα signalling on T regulatory cells and impact on Th1 disease 
models. We generated Foxp3-specific IL-4Rα deficient (FoxP3creIL-4Rα-/lox) mice through an 
X-linked Foxp3 promoter directed Cre recombinase activity. Using this mouse in an 
experimental model of listeriosis, we demonstrated that impairment of IL-4Rα–mediated 
signalling specifically within the Foxp3 T reg population resulted in significant difference in 
survival and decreased bacterial burden compared to the littermate control. This was further 
accompanied by smaller lesions sizes in the spleen and liver revealed by histopathological 
analysis. Flow cytometry analysis demonstrated enhanced effector T cells producing IFN-γ, IL-
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2 and increased expression of T-bet transcription factor signature at 7 dpi. In addition, 
abrogated signalling of IL-4Rα on T regs showed an increase in CD8+ T cells that produced 
granzyme B and IFN- γ necessary for killing of Lm. Furthermore, CD8+ T cells showed 
increased proliferation by Ki67 staining, better survival by BCl-2 levels and decreased 
apoptosis by activated  caspase-3 staining. Cytokines measured in the spleen upon 
restimulation with anti-CD3 and HKLM  and sera revealed a pro-inflammatory environment 
with a significant increase in IFN-γ at 7dpi. Liver homogenate showed an increase in TNF, IL-
10 and IL-4. Moreover, the co-culture of bone marrow-derived macrophages, T cells and T 
regs from Foxp3creIL-4Rα-/lox  mice confirm an important role the receptor in T regs in the 
control of Lm. Together, these results show a novel role of IL-4 responsive T regulatory cells in 
host immunity Lm infection in mice. 
3.1.2 IL-4Rα and Foxp3 mRNA expression during the progression of Lm infection in 
mice.  
We compared the expression of IL-4Rα and Foxp3 mRNA during the course of 2 to 10 days of 
listeria infection in both spleen and liver. This enables us to determine first whether Lm 
infection regulates the IL-4Rα and Foxp3 expression as a function of time. BALB/c mice were 
infected with 2×104 Lm sub-lethal dose intraperitoneally; this route was chosen because the 
oral route has been shown to have lower reproducibility, and also requires a higher inoculum 
dose as validated by us and others (Gaillard et al. 1991). After infection, at 2, 5, 7 and 10 days, 
Il4rα mRNA transcript was consistently decreased in the spleen (Figure 3.1A), suggesting Lm 
infection down-regulate Il4rα expression. Similarly, Foxp3 transcript decreases significantly 
early after infection at day 2 and day 5, however, it starts increasing at day 7 and restored to the 
levels uninfected spleen by day 10(Figure 3.1B). Conincidently, at day 10 mice do clear the Lm 
infection around day10 (Wang et al. 2011).  
In liver tissue, there was a transient increase in the expression of Il4rα up from naïve to 5 dpi 
and a decreased to the uninfected liver levels by day 10 (Figure 3.1C). In contrast to spleen, 
FoxP3 mRNA transcripts had no differences in the liver (Figure 3.1D). Therefore, Listeria 
infection modulates the of Il4rα expression, which reverts to naïve state at later stages of the 
infection. Furthermore, foxp3 expression signifiantly altered in spleen but not liver. These 




Figure 3. 1  mRNA expression of Il4rα and Foxp3 in spleen and liver of Lm infected mice: Mice 
were infected via an intraperitoneal route with 2x104 CFU Lm. At the indicated days, mice were 
sacrificed to measure (A) Il4rα (B) Foxp3 mRNA levels from the spleen and (C) Il4rα and (D) Foxp3 in 
the liver. Data is normalized to Hprt housekeeping gene. Data represented as mean ± SEM of n=3 
mice/time-point analysed by two-tailed, unpaired. Student t-test (*p<0.05, **p<0.01, ***p<0.001). 
 
3.1.3 The IL-4Rα expression on Foxp3 T reg dynamics alters over the course of infection 
in Foxp3creIL-4Rα-/lox mice during Lm infection. 
We followed up the differences observed in IL-4Rα (Figure 1.1) in vivo, in mice lacking IL-
4Rα specifically on Foxp3 T reg. Mice were infected with Lm with a sublethal dose of 2×104 
Lm/200µl and sacrificed 3 and 7 days post-infection. Spleen and liver tissue were harvested to 
generate single-cell suspensions to determine the expression of IL-4Rα on Foxp3 T regs by 
flow cytometry. We found a significant reduction of IL-4Rα protein levels at 3 and 7dpi 
(Figure 3.2A & C) both in the spleen and the liver in Foxp3creIL-4Rα-/lox animals relative to the 
littermate control, confirming a cell-specific deletion of the receptor on Foxp3 T regs in both 
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organs during the course of the infection, as expected, not to the levels in global IL-4Rα 
knockouts. The characterization of Foxp3creIL-4Rα-/lox mice had been described by our group 
previously and there were not any irregularities reported in this mouse at (Aziz et al. 2018). 
 
Figure 3.2 Confirmation of IL-4Rα knockdown in Foxp3 T cells during  Lm infection. Mice were 
infected with low dose Lm 2×104 Lm/200µl, single-cell suspension from liver and spleen was generated 
and cells were analysed by flow cytometry to determine IL-4Rα  expression on Foxp3 T regs (A) 
Diagramatic representation of Lm primary infection and gating strategy (B) Histogram representation 
from IL-4Rα-/- (grey tinted), Foxp3creIL-4Rα-/lox (solid line) and IL-4Rα-/lox (dashed line) tissues (C) IL-
4Rα geometric mean fluorescence intensity (GMFI) quantification on spleen and liver at 3dpi and (D) 
7dpi. Error bars denote mean ± SEM. Data shown are representative of 2 independent experiments. n = 





3.14 Effect of  IL-4Rα impairment on the functionality of Foxp3 T reg during Lm 
infection. 
To assess whether the loss of IL-4Rα on Foxp3 T reg affected the quality of T regulatory cells 
(CD4+ Foxp3), we use the expression of Foxp3 quantity (%) during infection by checking the 
expression of Foxp3+GMFI by flow cytometry during Lm infection at 3 and 7 days in the 
spleen and liver. During shistosomaisis infection, STAT-6 phosphorylation in Foxp3creIL-
4Rα−/lox  mice was significantly reduced compared to IL-4Rα−/lox mice upon rIL-4 stimulation. 
Indicating the role of IL-4Rα in the stability of T regs during infection (Aziz et al. 2018). 
However, at a steady-state, the quality of the Foxp3 T reg population was not affected by the 
loss of the receptor. In vitro polarization experiments of sorted CD4+CD25- cells by anti-CD3, 
anti-CD28 and TGF-β stimulation from Foxp3creIL-4Rα−/lox mouse showed a higher rate of 
conversion to CD4+CD25+ Foxp3 T cells (induced Treg cells) compared to littermate controls; 
however lower proliferative capacity.(Aziz et al. 2018)  In infectious settings with Schistosoma 
mansoni, there was a significant decrease in the expression of Foxp3 on CD4 T cells and 
consequently an impaired accumulation of Foxp3 Treg cells at peripheral tissues (Aziz et al. 
2018). Similarly, in Lm infection, there was a significant decrease in the expression of Foxp3 at 
3dpi (Figure 3.3 A) and 7dpi (Figure 3B) in the spleen, but not in the liver tissue. This suggests 
that though the Foxp3 T regs population is not affected by the loss of IL-4Rα at a steady-state, 
during infection settings the quality and possible the functionality of Foxp3 T regs are affected.  
We did not observe much differences in the liver, probably due to insufficient deletion of IL-






Figure 3.3 Functional decrease of Foxp3 in Foxp3creIL-4Rα−/lox mice in the spleen during Lm 
infection: Mice were infected with Lm via intraperitoneal injection with a sub-lethal dose of 2x104 
CFU/200µl, mice were sacrificed at 3 and 7dpi and the expression Foxp3 on CD4+ T cells are evaluated 
by flow cytometry. Foxp3 GMFI expression liver and spleen at (A) 3dpi and (B) 7dpi. Data are shown 
as mean ± SEM representative of three independent experiments, *, p˂0.05, ** p˂0.01. Student’s t-test. 
 
3.1.5 Foxp3creIL-4Rα-/lox mice survive  better than their litter during Lm infection  
With the quality of Foxp3 T regs being affected, we aim to understand the affect on survival 
and bacterial burden as a consequence of absence IL-4Rα on Foxp3 T reg during Lm infection. 
We infected a lethal dose (LD50) of Lm (2x10
5 Lm CFU/mouse) intraperitoneally to Foxp3creIL-
4Rα-/lox mice and littermate control (IL-4Rα-/lox) animals. Higher mortality was observed in 
control littermate relative to Foxp3creIL-4Rα-/lox mice (Figure 3. 4A). This reveals a possible 
role IL-4Rα on Foxp3 during Lm infection possible as a consequence of reduced functional 
Foxp3 as observed in Figure 3.3. To better understand the survival of the Foxp3creIL-4Rα-/lox 
mice, we infected mice with a sublethal dose of Lm (2x104 Lm CFU/mouse) for time-kinetic 
experiments. At 3dpi and 7dpi, mice displayed a significantly reduced spleen bacterial burden 
(Figure 3.4B), but liver burdens were unaffected (Figure 3.4C). This suggests there is a tissue 




Figure 3.4 IL-4Rα deletion on Foxp3 T reg renders mice resistant to Lm infection. Mice were 
infected with Lm to evaluate survival and bacterial burden (A) Survival curve of Foxp3creIL-4Rα-/lox and 
littermate control (n=8-10 mice/group) following infection with a sub-lethal dose of 2x104 CFU/200µl 
Lm. Statistical significance determined by two-tailed Mantel-Cox test (p= 0.0123) (B) Spleen and (C) 
liver bacterial burden was determined at 3- and 7-days post-infection following infection with 2x104 
CFU (n=10-15mice/group). Error bars denote mean ± mean and representative of two experiments (A) 
or pooled from four independent experiments (B-C). Data analysied by two-tailed unpaired Student’s t-
test, unpaired.*, P < 0.05; **, P < 0.01; ***, P < 0.001 
 
3.1.6 Absence of IL-4Rα on Foxp3 T reg results in the reduced pathology and lesion size 
in liver and spleen during Lm infection  
Since FoxP3creIL-4Rα-/lox mice survive better to Lm in the mortality study (Figure 3.4A), we 
performed hematoxylin and eosin staining (H&E) to evaluate histopathology of the spleen and 
liver during Lm infection as described above. At 3 and 7 days post-infection, Foxp3creIL-4Rα-
/lox mice displayed smaller lesion size measured by atrophic white splenic pulp compared to 
their littermate control (Figure 3.5A). Similarly, in the liver, we observed decreased lession 
size in Foxp3creIL-4Rα-/lox mice when compared to littermate control (IL-4Rα-/lox) mice (Figure 
3.5B). This suggests that deletion of  IL-4Rα on T regulatory cells decreased cellular 







Figure 3.5 Decreased tissue pathology in Foxp3creIL-4Rα-/lox mice during Lm infection in 
peripheral organs.  Foxp3creIL-4Rα-/lox and littermate control mice were intra-peritoneally infected 
with 2×104 Lm/200µl. At 3 dpi and 7dpi spleen and liver, tissues were formalin-fixed and stained with 
H&E for histopathology. Three cuts 30µm apart per histology sections were analysed (30µm apart, 
scale bar =100µm) (A) Diagrammatic representation of spleen with arrows showing white pulp atrophy. 
(magnification ×200, circled areas indicates cellular infiltration). (B) Diagrammatic representation of 
cellular infiltration into liver tissue (C) Quantification of splenic atrophic areas; (D) quantification of 
liver lesion size. Results are representative of three independent experiments with 6 to 8 mice/group. 
Data are expressed as mean ± mean, two-tailed unpaired Student t test . P > 0.05; * P < 0.05, ** P < 




3.1.7 Liver cytokine reponses in Foxp3creIL-4Rα-/lox mice during Lm  
To understand the underlying cause of Foxp3creIL-4Rα-/lox survival benefit (Figure 3.4A) and 
improved histopathology (Figure 3.5B), we performed cytokine ELISA on liver homogenates 
at 3 and 7 days post-infection. At 3 days post-infection, there was a significant decrease in pro-
inflammatory cytokines;  IFN-γ, IL-12p40, and IL-6, however, TGF-β, TNF, IL-4 and IL-10 
levels remained unaffected (Figure 3.6A). In contrast at 7 days post-infection, there was a 
significant increase in TNF, IL-10 and IL-4, suggesting a dampening effect in the absence of 
IL-4Rα on Foxp3 T regs; however, there were no differences in IL-17, IFN-γ, TGF-β, IL-
12p40 and IL-6 at this time-point (Figure 3.6B). Decreased pro-inflammatory cytokines also 
account for reduced tissue damage at the liver.  
 
Figure 3.6 Lack of IL-4Rα expression on Foxp3 T reg cells impairs hepatic cytokines during Lm 
infection. Mice were infected intra peritoneally with 2×104 Lm and sacrificed 3dpi and 7dpi and 
cytokines ELISAs performed on liver homogenates at (A) 3dpi and (B) 7dpi. Error bars denote mean ± 
SEM. Data shown are representative of one of three independent experiments with a sample size of n = 
6–8 mice per group and analysed by two-tailed, unpaired, Student’s t-test. *p < 0.05, **p < 0.01, and 
***p < 0.001  
 
3.1.8  Ex vivo stimulation of splenocytes show a proinflammatory cytokine profile in mice 
lacking IL-4Rα on Foxp3 T regs during Lm infection 
We next examined the spleen cytokine profile following restimulation with either heat-killed 
Lm (HLKM) or anti-CD3 or left unstimulated (Figure 3.7A-E). At 3dpi, there were no major 
differences in the cytokine profiles in IFN-γ, IL-10, and TNF (Figure 3A-C). At 7dpi, there was 
a significant increase in IFN-γ and IL-10 upon anti-CD3 stimulation (Figure 3.7D-E). This 
modest increase in IFN-γ likely contributed in observed decreased bacterial burdens can be an 
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indicator of bacterial clearance since IFN-γ increase plays a cricial role in the clearance of Lm 
clearance during infection (Buchmeier & Schreiber 1985). 
 
 
Figure 3.7 Pro-inflammatory cytokines are enhanced in Foxp3creIL-4Rα-/lox mice during Lm 
infection. Spleen cells were re-stimulated with α-CD3 and heat-killed Lm (HKLM) or left unstimulated 
for 72 hours, after which cytokines were measured in the supernatants by ELISA at 3dpi (A) IFN-γ  (B) 
IL-10  (C) TNF and at 7dpi (D) IFN-γ  (E) IL-10 (F) IL-6. Data is representative of two individual 
experiments with mean values ± SEM. Statistical analysis was performed, by two-tailed unpaired 
Student t-test,(*, p˂0.05, **, p˂0.01) 
 
3.1.9 Pro-inflammatory cytokines are enhanced  in the sera of Foxp3creIL-4Rα-/lox mice 
during  Lm infection 
Since we observed an increase in IFN-γ secretion upon splenocyte restimulation, we sought to 
investigate whther serum cytokines were affected differentially in Foxp3creIL-4Rα-/lox mice 
during Lm infection with sub-lethal dose. There was a significant increase in IL-1β (Figure 
3.8A), increase in IL-12p70 (Figure 3.8B ), increase in IFN-γ (Figure 3.8C) and increase in 
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TGF-β (Figure 3.8F) at 7dpi for Foxp3creIL-4Rα-/lox mice. There was no change in TNF (Figure 
3.8E) and a decrease in IL-1β and IL-1α at 3dpi respectively (Figure 3.8 A&D). An increase in 
pro-inflmammtory cytokines in serum including IFN-γ suggests an important role of IL-4Rα 




Figure 3.8 Increased serum cytokine secretion in Foxp3creIL-4Rα-/lox mice.  Mice were infected with 
a sublethal dose Lm (2×104 CFU ) Cytokine concentrations were measured in the serum by ELISA at 3 
and 7 dpi (A) IL-1β, (B) IL-12p70 (C) IFN-γ, (D) IL-1α, (E), TNF and (F), TGF-β. Data is 
representative of two individual experiments with mean ± SEM. Grey bars representing IL-4Rα-/Lox, 
white bars Foxp3creIL-4Rα-/lox mice. Statistical analysis was performed by two-tailed unpaired  Student 
t-test. (*, p ≤ 0.05, **, p ≤ 0.01) 
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3.1.10 Absence of IL-4Rα signalling on Foxp3creIL-4Rα-/lox mice alter cell numbers and 
myeloid population during Lm infection 
To better understand which cell population were involved for the augmented infiltration 
(Figure 3.5 A-D), animals were infected with a sub lethal dose of Lm and sacrificed at 3 and 
7dpi. Single-cell suspensions were prepared from the liver and spleen and analysed for the 
myeloid cell populations. We first evaluated the total cell numbers in the spleen and liver. 
There was a significant increase in total cell numbers cell numbers in the Foxp3creIL-4Rα-/lox 
mice compared to littermate controls in the spleen at 3 and 7 dpi (Figure 3.9A) but no 
significant differences at the liver (Figure 3.9B). There was a significant increase of 
macrophage population in the Foxp3creIL-4Rα-/lox mice at 7dpi (Figure 3.9 C) and a significant 
increase of DCs at 3 dpi (Figure 3.9 D) in the spleen. In addition, an increase of neutrophils at 
both 3 and 7 dpi in the Foxp3creIL-4Rα-/lox mice was observed. There was a decreased number 
of macrophages in the liver at both time points. (Figure 3.9 F) and a decrease in neutrophils at 
7 dpi (Figure 3.9 H). There were no differences in DCs in the liver at both time points (Figure 
3.9 G). An increase in neutrophil is known to control Lm during the early stages of the disease 
which can explain decreased splenic bacterial burden in the Foxp3creIL-4Rα-/lox mice (Witter et 
al. 2016). This shows that the recruitment of infiltrating populations varied between the spleen 






Figure 3.9 Foxp3creIL-4Rα-/lox mice showed increased total cell numbers and myeloid cell 
population in the spleen during Lm.  Mice were intraperitoneally infected with Lm, total cell counts 
were counted by Trypan Blue exclusion assay. Extracellular staining was performed on macrophages, 
dendritic cells, and neutrophils at 3 and 7dpi. (A) Spleen total cell counts, (B) total cell count numbers 
in the liver. Spleen (C) macrophage, (D) DC, (E) neutrophil, and liver (F) monocyte-derived 
macrophage, (G) DC and (H) neutrophil counts are shown. Data is representative of two experiments. 
Grey bars representing IL-4Rα-/Lox, white bars representing Foxp3creIL-4Rα-/lox mice. All data are shown 
as mean ± SEM and are representative of two independents experiments, compared to control. Data is 




3.1.11 Absence IL-4Rα signalling on Foxp3creIL-4Rα -/lox mice on other lymphoid cells 
during Lm infection 
Cytokine secretion during infection affect T cells and their surrounding cells. We evaluated T 
cells since they play an important role during Lm infection (Shedlock et al. 2003; Pamer 2004; 
Graw et al. 2012). We showed that loss of IL-4Rα signalling on Foxp3 creIL-4Rα -/lox mice 
affected the secretion of pro-inflammatory cytokines (Figures 3.6, 3.7 & 3.8), improved 
histopathology (Figure 3.5) and enhanced survival (Figure 3.4). We investigated T cell 
population to evaluate the effect on lymphocyte populations (CD4+T cell and CD8+T cell) in 
the liver and spleen at 3 and 7dpi. CD4+ T cell at the spleen and liver was similar for both 
groups except there was a slight decrease in CD4+ T cells at 7dpi in the liver at 7dpi (Figure 
3.10A and C). There was a significant increase of CD8+ T cell population in the spleen (Figure 
3.10B) whilst it remained unaffected in the liver (Figure 3.10B and D). Since CD8+ T cells are 
very important for Lm clearance (Tvinnereim et al. 2002; Zaiss et al. 2008) their increased 
numbers in Foxp3creIL-4Rα -/lox mice are quite notable and we further analysed these cells to 
understand the secretion of other intracellular cytokines and granzyme-B produced mainly by 




Figure 3.10 CD4/CD8 T cells population during Lm infection of Foxp3creIL-4Rα-/lox mice:. Mice 
were infected with 2x104 CFU via intraperitoneal injection. Single cell suspensions of total splenic and 
liver cells were prepared and stained for (A) CD4 spleen cells, (B) CD8 spleen cells, (C) CD4 liver 
cells, (D) CD8 liver cells and acquired on BD Fortessa. Grey bars representing IL-4Rα-/Lox, white bars 
representing Foxp3creIL-4Rα-/lox mice. Data are presented as mean ± SEM of n=6-8 mice/time point 







3.1.12 Ex-vivo T cell cytokine responses in Foxp3creIL-4Rα-/lox mice during Lm infection  
With an increased IFN-γ released by splenocytes (Figure 3.7D), serum (Figure 3.8C), and 
increased CD8+ T cell numbers at 7dpi (Figure 3.10B); we sought to understand the underlying 
mechanism in the spleen at 7dpi. We infected mice with 2×104 CFUs low dose Lm and 
sacrificed at 7dpi. Taking into consideration that CD8+ cytotoxic T cell is one of the 
predominant cellular population that kills Lm (Harty & Badovinac 2002); we re-stimulated 
cells with heat-killed Lm (HKLM), PMA/ionomycin or left unstimulated to perform 
intracellular cytokine staining for IFN-γ, IL-2, IL-17, TNF and granzyme B. In unstimulated 
cells, there was a significant increase in CD4+ T producing IFN-γ and IL-2 in Foxp3creIL-4Rα-
/lox mice (Figure 3.11A) but not in CD8+ T cells. Stimulation with HKLM also led to increases 
in IL-2 but not in IFN-γ, IL-17 and TNF in both in the CD4+ and CD8+ T cells. (Figure 3.11B). 
Moreover, stimulation with PMA/ionomycin led to a significant increase in the production of 
IFN-γ and IL-2 but not in IL-17 and TNF levels in both CD4 and CD8 T cells of Foxp3creIL-
4Rα-/lox mice (Figure 3.11C). Granzyme B is an important Listeria monocytogenes host killing 
protease produced by cytotoxic cells, thus we checked if the deletion of IL-4Rα signalling of T 
regs affected the ability of  CD4+ T cells and CD8+ T cells to produced granzyme B. Granzyme 
B is critical for the killing of Listeria monocytogenes (Kaufmann 1993). In addition to CD8+ T 
cells activated CD4 T cells are also known to produce granzyme B (Takeuchi & Saito 2017). 
We observed a significant increase in the production of granzyme B production in both CD4+ T 
cell and CD8+ T cells in Foxp3
creIL-4Rα-/lox mice. (Figure 3.11D and E). These results suggest 






Figure 3.11 Intracellular cytokine profile in splenic T cells during Lm infection. Animals were 
intraperitoneally infected with 2x104 Lm. Single cell suspension was prepared and  2 million cells were 
then seeded to either stimulate cells in (A) media (B) heat-killed Lm and (C) 
PMA(20ng/ml)/ionomycin(1µg/ml) (D) Splenic CD4 T cell GranzymeB (E) Splenic CD8 T cell 
GranzymeB  for 6 hours followed by monensin 200µM blockage to perform intracellular cytokine 
staining and acquired on the Fortessa. Grey bars representing IL-4Rα-/Lox, white bars representing 
Foxp3creIL-4Rα-/lox mice. Data represented as mean ± SEM of n=6 mice/time point from three 




3.1.13 Effector CD4+ T cell memory responses in Foxp3creIL-4Rα -/lox mice are enhanced 
during Lm infection 
After infection with Lm, CD4+T cells are activated. Considering that, we noticed a continuous 
increase in IFN-γ cytokine in the splenic cells (Figure 3.7D), serum (Figure 3.8C) and in ex 
vivo stimulated splenic cells (Figure 3.11). We next asked if these cells had augmented effector 
phenotype in the Foxp3creIL-4Rα-/lox mice at 7 days post-infection. Foxp3creIL-4Rα-/lox mice had 
significantly higher effector/effector memory phenotype (CD44highCD62Llow) compared to 
littermate controls (Figure 3.12). This high effector phenotype can possibly explain the IFN-γ 
production; a key Th1 response cytokine. Collectively, this data suggests that upon deletion of 
IL-4Rα on Foxp3creIL-4Rα-/lox mice, an augmented effector T cell memory phenotype is 
acquired that leads to the production of IFN-γ and IL-2 cytokines. Also, CD4+ T cells and 
CD8+T cells produced increased granzyme B in Foxp3creIL-4Rα-/lox mice. 
 
Figure 3.12 Abrogation of IL-4Rα expression on Foxp3 cells enhance CD4 T cell effector function. 
Mice were infected with 2x104 CFU via intraperitoneal injection. A single-cell suspension of total 
splenic cells analysed to determine effector T cell proportion by flow cytometry. (A) Diagrammatic 
representation of the effector population pre-gated on CD4 cells. (B) Quantification (%) of effector T 
cells. Grey bars representing IL-4Rα-/Lox, white bars representing Foxp3creIL-4Rα-/lox mice. Data 
represented as mean ± SEM of n=6-8 mice/time point from three independent experiments and analysed 
by two-tailed, unpaired Student t-test (*p<0.05, **p<0.01). 
 
3.1.14 Absence IL-4Rα expression on Foxp3 T reg cells enhance Tbet signature 
In order to delineate the effector phenotype function coupled with IFN-γ production in serum 
and spleen; we checked the expression of transcriptional factor T-bet on T helper and cytotoxic 
T cells. The T-bet expression is known for the control of the Th1 phenotype and production of 
59 
 
cytokines like IFN-γ, IL-2, and TNF (Szabo et al. 2000). Remarkably, the absence of IL-4Rα 
on Foxp3 T reg cells resulted in a significant increase in the percentage of T-bet expression in 
both CD4+ T cells and CD8+ T cells upon Lm infection at 7dpi (Figure 3.13A-D). The T-bet 
transcriptional factor is known to promote the growth and differentiation of the Th1 subset 
while concomitantly blocking the other subsets (Seder & Paul 1994). However, we found no 
differences in GATA3 in Foxp3creIL-4Rα-/lox mice (Figure 3.13E and F). These results suggest 
that there is a shift towards a Th1 phenotype in the absence of IL-4Rα expression on Foxp3 T 







Figure 3.13 T-bet transcriptional factor expression is significantly enhanced in Foxp3creIL-4Rα -/lox 
mice during Lm infection. Mice were infected intraperitoneally with 2 x 104 Lm. A single-cell 
suspension of total splenic cells was stained for intranuclear transcriptional factors T-bet and GATA-3 
from mice sacrificed at 7dpi (A) Representative flow cytometry plot of the frequency of T-bet+ CD4+ 
(C) T-bet+ CD8+, (B) quantification of T-bet+ CD4+ and (D) T-bet+ CD4+ populations. (E) frequency of 
GATA-3+CD4+ cells. Grey bars representing IL-4Rα-/Lox mice while white bars Foxp3creIL-4Rα-/lox mice. 
Data shown are representative of two independent experiments (*p<0.05, **p<0.01) analysed by two-




3.1.15 Abrogated IL-4Rα-mediated signalling on Foxp3 T reg cells leads to expansion and 
survival of CD8+ T cells during Lm infection. 
To better understand the histopathological destruction of white splenic pulp in the littermate 
control compared to Foxp3creIL-4Rα-/lox at 7 dpi, we checked activated caspase 3 expression 
which is a marker of apoptosis, the physiological process in the elimination of cells. We also 
assessed the anti-apoptotic B cells lymphoma-2 (Bcl-2) expression since it is known to inhibit 
apoptosis (Bissonnette et al. 1992). It has been reported that infection with Lm causes the 
destruction of the white pulp by apoptosis in vitro and in vivo (Carrero et al. 2004). Therefore, 
we assessed the deletion of IL-4Rα deletion on T regs and the effect on apoptosis and survival 
of CD8+ T cells. Also, we asked if the absence of IL-4Rα on T reg could lead to more 
expansion and survival of these CD8+ T cells as observed in Figure 3.10B. We hypothesized 
this based on reduced Foxp3 T reg population in the IL-4Rα deficient T reg mice (Figure 3.3) 
and might affect the effect the T reg/effector balance. The presence of Bcl-2 and Ki-67 markers 
are indicators of cell proliferation and nuclear protein activity during cell division. We 
investigated CD8/CD4 T cell proliferation. We observed significant increase in CD8+Ki-67+ 
(Figure 3.14A&B) and CD8+BCL-2+ Caspase3+ (Figure 3.14C) in Foxp3creIL-4Rα-/lox mice. 
However, no differences in CD4+Ki-67+ (Figure 3.14F), CD4+BCL-2+ (Figure 3.14F) and 
CD4+Caspase3+ (Figure 3.14G). Following expansion, most CD8 T cells die after infection, 
with lesser memory population that is capable of surviving and offering long lasting protection 
during the subsequent challenge from the same antigen (D’Cruz et al. 2009). These results 
suggest in the absence of IL-4Rα on Foxp3 T regs, CD8 T cells expand, with decreased 
apoptosis and better survival. We did not, however, check on long term memory and survival at 




Figure 3.14 CD8+ T cells significantly expand in the spleen of Foxp3creIL-4Rα-/lox mice during Lm 
infection: Mice were infected intraperitoneally with low dose Lm (2x410CFU/mouse). A single-cell 
suspension of total splenic cells was stained for BCL-2 and Ki-67 protein in CD8/CD4 T cells 7dpi. (A) 
Frequency of CD8+Ki-67+ (B) quantification of CD8+Ki-67+ (C) CD8+Caspase3+ T cells (D) CD8+BCL-
2+ T cell (E) CD4+Ki-67+ T cells (F) CD4+BCL-2+ T cells and (G) CD4+Caspase3+ T cells. Grey bars 
representing IL-4Rα-/Lox mice while white bars Foxp3creIL-4Rα-/lox mice Data represented as mean ± 
SEM of n=6-8 mice/time point from two independent experiments and analysed by two-tailed unpaired 






3.1.16 A shift towards Th1-type immune responses in Foxp3creIL-4Rα-/lox T cells during ex 
vivo stimulation 
In order to determine whether the increased protection observed in Foxp3creIL-4Rα-/lox mice 
during primary infection with Lm was accompanied by an altered immune response ex vivo, we 
examined cellular activation and cytokine responses by flow cytometry in a co-culture of bone 
marrow-derived macrophages (BMDM) and T cells from Foxp3creIL-4Rα-/lox mice and 
littermate controls. In naïve mice, CD4+CD25+ are widely used as a marker for T reg. The 
depletion of CD25+ in naïve mice has been shown to develop autoimmunity similar to T regs 
(Foxp3) deficient (Setoguchi et al. 2005; Zelenay et al. 2005; Chai et al. 2008). We carried out 
co-culture experiment with a 1:1 ratio (macrophages: CD4+CD25- T cells), 1:3 ratio 
(macrophages: CD4+CD25- T cells) or 1:3:1 ratio (macrophages: CD4+CD25- T cells: 
CD4+CD25+ T cells). Flow analysis revealed a decreased population of T reg (CD4+Foxp3+) in 
the Foxp3creIL-4Rα-/lox mice compared to the littermate control (Figure 3.15A). This was in line 
with in vivo results obtained in Figure 3.3 and the presence of CD4+CD25+ cells evidently 
increased the Foxp3 signature. We performed T cell effector functions on the various groups. 
In the group of ratios 1: 3, there was a significant increase in CD4 effector function in both 
groups evident of the addition of CD4+CD25- effector cells. There were no differences between 
the T cells isolated from littermate control and Foxp3creIL-4Rα-/lox spleens. Upon the addition 
of CD4+CD25+ T cells (T regs), there was a suppression of the effector function (Figure 
3.15B). There were no differences in central memory in the different subsets. The addition of T 
regs significantly suppressed central memory (Figure 3.15C). There was an increase in naïve T 
cells with the increased CD4 T effector cell ratios. Strikingly there was an increase naïve T cell 
phenotype in the Foxp3creIL-4Rα-/lox mice in the (1:3:1 ratio) group than littermate control 
(Figure 3.15D). There was a significantly increased proliferation of T cells from ratio 1:3 
compared to ratio 1:1, proliferation was not affected by the addition of T regs (ratio 1:3:1). We 
did not observe differences between Foxp3creIL-4Rα-/lox mice and littermate controls within 
each group (Figure 3.15E). Consistent with in vivo results, where increased proliferation was 
observed only with CD8+ T cells but not in CD4+ T cell.  
We further analysed the cytokines from supernatants and found IL-1β was significantly 
increased when T cells added to macrophage co-culture, most probably due to the activation of 
macrophages by IFN-γ. This was significantly reduced with the addition of T regs though no 
differences were found between the groups (Figure 3.15G). There were no differences in IFN-γ 
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secretion between T cells from the littermate controls and Foxp3creIL-4Rα-/lox (Figure 3.15H). 
IL-10 was secreted by macrophages and in the presence of T regs in a significant amount 
compared to groups with no T regs. Interestingly mice lacking IL-4Rα on T regs showed lesser 
secretion of IL-10 compared to the littermate control, suggesting compromised suppressive 
function (Figure 3.15I). Therefore, the absence of IL-4Rα on T regs (Figure 3.15D) led to 








Figure 3.15 Decreased suppressive capacity of T regs from  Foxp3creIL-4Rα-/lox mice in vitro  
BMDMs were derived from IL-4Rα-/lox mice, co-cultured with T cells (CD4+CD25- or CD4+CD25+) 
from IL-4Rα-/lox and Foxp3creIL-4Rα-/lox mice after stimulation with HKLM (MOI 1:5) for 72 hours. (A) 
Percentages of CD4+Foxp3+ cells, (B) CD4 T effector memory, (C) central memory, (D) naïve T cells 
determined by flow cytometry. (E) Ki-67 T cell proliferation, (F) IL-12p40, (G) IL-1β, (H) IFN-γ, (I) 
IL-10 cytokines determined ELISA. A single experiment is shown with values ± SEM of triplicates 1:1 
ratio represents (1-macrophages: 1-CD4+CD25- T cells), 1:3 ratio (1-macrophages: 3-CD4+CD25- T 
cells) 1:3:1 ratio (1-macrophages: 3-CD4+CD25- T cells: 1-CD4+CD25+ T cells). Statistical analysis was 
performed using unpaired Student t-test (*, p ≤ 0.05, **, p ≤0.01 ***, p ≤ 0.001). 
 
3.1.17 IL-4Rα-mediated signalling on Foxp3 T reg cells is indispensable for secondary 
responses in Lm infection 
To further understand the role of IL-4Rα signalling on T reg during long term memory after 
immunization, littermate controls and Foxp3creIL-4Rα-/lox mice were immunized with 1x104 
CFU/mouse and left for 30 days to permit complete bacterial clearance and acquire 
immunological memory (Figure 3.16A). Mice were re-challenged 30 days after with a lethal 
dose, 100 times the dose of the primary vaccination (1x106). Mice were monitored for 
mortality. In parallel, mice were sacrificed at two days post-infection to assess the spleen and 
liver burden. Increased mortality was observed in Foxp3creIL-4Rα-/lox mice compared to their 
littermate control (Figure 3.16B). Strikingly, 50% of the control littermates survived after 15 
days whereas all the Foxp3creIL-4Rα-/lox mice died before day 6. Consistent with survival, 
Foxp3creIL-4Rα-/lox mice had significantly increased bacterial burden both in the spleen and the 
liver (Figure 3.16B). Susceptibility to infection in Foxp3creIL-4Rα-/lox mice was accompanied 
by a significant increase in spleen and liver lesions (Figure 3.16 C and D). To better understand 
why the Foxp3creIL-4Rα-/lox mice were susceptible despite initial protection in the primary 
infection, we performed cytokine ELISA on the liver homogenates, intracellular flow 
cytometry for spleen cytokines. In the liver, there were significant increases in IFN-γ, TGF-β, 
IL-10 and IL-12p70 (Figure 3.16F) levels in Foxp3creIL-4Rα-/lox mice. On the other hand, there 
was a slight decrease in IL-1α and IL-1β (Figure 3.16F) in mice lacking IL-4Rα specifically on 
Foxp3 T reg. IL-10 and TGF-β are well known immune-regulatory cytokines that act in to 
protect tissues and limit damages from excessive pro-inflammatory responses. However, 
excessive production can also inhibit the effector function of the pro-inflammatory cytokines. 
(Sanjabi et al. 2009; Barbosa et al. 2015). Paradoxically, there was a significant secretion of 
IFN-γ, and IL-12p70 pro-inflammatory cytokines. There were no significant differences in IL-4 
secretion at the liver. These results suggest that pro-inflammatory cytokine secretion is 
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sustained in Foxp3creIL-4Rα-/lox mice during a re-challenged that might likely contribute to 
tissue damage and therefore increased mortality. Single-cell CD4+ T cells staining revealed a 
significant increase in IL-4 and IL-10 and a decrease in IFN-γ in Foxp3creIL-4Rα-/lox mice. This 
suggests IL-4 and IL-10 might be inhibiting the IFN-γ which is necessary for Lm clearance, 
hence the observed increased bacterial burden in the spleen. (Figure 3.16G)  This shows that 
intact IL-4Ra signalling is required to modulate host immune responses during secondary 







Figure 3.16 Increased Mortality and bacterial burden in Foxp3creIL-4Rα -/lox mice during Lm 
infection re-challenged:  Mice were infected intraperitoneally with Lm with low dose Lm (1x104 
CFU/mouse) and 30 days later re-challenged with 100-fold the initial dose (1x106). (A) Diagrammatic 
representation of secondary infection (B) Survival curves of mice, (C) spleen and liver Lm burden 
sacrificed 2 days post-challenge. (D) Formalin-fixed liver sections analysed for tissue pathology by 
H&E staining (circles indicating lesions). (E) Quantification of liver lesion size. (F) Liver homogenate 
cytokines of IFN-γ, IL-17, IL-1β, IL-1α, IL-6, TGF-β, IL-10, IL-4, TNF, IL-12p40, IL-12p70 (G) 
Splenic CD4+ T cell producing cytokine of IFN-γ, IL-4, IL-10. Grey bars representing IL-4Rα-/Lox mice 
while white bars Foxp3creIL-4Rα-/lox mice Data represented as mean ± SEM of n= 5-6 mice/time point 
from two independent experiments and analysed by two-tailed, unpaired Student t-test (*p<0.05, 
**p<0.01, *** p < 0.001). 
 
 
3.2 Section two 
3.2.1 Abstract Mtb infection  
IL-4Rα-signalling on T reg cells is dispensable for Mycobacterium tuberculosis pathology 
and bacterial burden in mice 
Immune response to Mtb is strongly controlled by the host immune system during infection, 
limiting the growth of bacteria and lung tissue damage. The processes that control these are 
complex and involves a broad range of cell types and population. T regulatory cells play a very 
important role during this process. Though their role can be beneficiary in controlling 
inflammation, it has been shown to be detrimental under certain circumstances such as 
delaying the arrival of effector T cells necessary for control of Mtb in the lungs. However, the 
conditions that affect T regs during infection have not been well studied.  
Using publicly available cohort studies, we found that human IL-4Rα and Foxp3 significantly 
alters in the blood of TB patient. Here, we investigated the lack of IL-4Rα signalling on 
CD4+Foxp3 cells (Tregs) during Mtb infection in mice. We observed similar survival of Mtb-
infected FoxP3creIL-4Rα-/lox mice to littermate control. Furthermore, no differences were 
observed in acute and chronic bacterial burden and histopathological scores of lungs. Mtb 
infected FoxP3creIL-4Rα-/lox however, exhibited significantly enhanced CD4+ T effector cells 
which translated increase IFN-γ, IL-17 and TNF upon ex-vivo stimulation with H37Rv. 
However, cytokine production alone does not determine disease outcome. Overall, we show an 
important role of IL-4Rα signalling on Foxp3 and its effect to mediate effector function. 
Effector T cell enhancement did not translate into survival nor improved lung histopathology. 
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This indicates that modulation of the IL-4Rα and Foxp3 signalling in mice do not influence the 
disease outcome. 
3.2.2 Introduction Mtb Section 
In the previous section, we studied Listeria monocytogenes (Lm) as a model for the study of an 
intracellular pathogen. To further expand our knowledge on another intracellular pathogen of 
public health importance, we asked whether the IL-4Rα deletion on Foxp3 T reg cells could 
have similar effector function and phenotype during Mtb infection. Mtb is the causing agent of 
tuberculosis (TB). TB remains one of the greatest infectious diseases worldwide, with over 
30% of individuals harbouring the microbe associated with huge mortality and morbidity 
(WHO 2018). The adaptive arm of immune sytem is essential for Mtb response during 
infection. During Mtb infection, T cell response is significantly delayed compared to other 
pathogens like Lm. This delay occurs at multiple stages including; late arrival of antigen-
presenting dendritic cells carrying Mtb to the draining lymph nodes. The delayed proliferation 
of effector T-cells necessary for cytokine secretion. Also, this delay occurs due to the ability of 
Mtb to favour necrosis over apoptosis to escape from macrophage killing and delayed 
presentation to T cells (Larson et al. 2013).  Foxp3 T reg has as function to suppress and 
dampens excessive immune responses but this role can be detrimental or beneficiary during 
infection depending on the disease model. T reg is recruited into the lungs during the first 
weeks of infection with less circulating T reg in the blood suggesting migration to the 
peripheral tissues (Burl et al. 2007).  T reg migration to the peripheral tissues is a natural 
phenomenon in most diseases following infection and inflammation (Campbell & Koch 2011). 
A correlation between the T reg and the bacterial colony forming unit (CFU) has been 
established with excessive T reg playing a detrimental role in prohibiting action of pro-
inflammatory cytokine effector killing (Marin et al. 2010). This has also been correlated by 
increased T reg at the site of caseating granuloma (Welsh et al. 2011). T reg effector balance is 
therefore tilted towards T effector function during Mtb infection, suggesting the infiltration of 
T reg may be detrimental during pulmonary TB (Welsh et al. 2011). T reg cells have the ability 
to suppress CD4+ T cell function also, depletion of T reg cells during in vitro studies resulted in 
increased proliferation of T effector cells, that resulted in increased secretion of IFN-γ (Chen et 
al. 2007). Similarly, in mice studies depletion of T reg had a similar effect to in vitro studies 
(Fontenot et al. 2005; Kohm et al. 2006). To further validate the role of T reg in Mtb infection, 
sorted CD4+CD25+ (thymic T reg at naive state) and sorted CD4+CD25- (effector T cells) have 
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been shown to control Mtb differently. A significant decreased in bacterial burden in the 
effector population was witnessed compared to the (CD4+CD25+) T reg, suggesting a possible 
detrimental role of T reg during Mtb infections (Kursar et al. 2007). T reg plays a very 
important role in autoimmunity, targeting these population for complete deletion as an 
approach for host-directed therapy against Mtb is not tenable. Selective manipulation of this 
population without tempering with its principal function could be an alternative for host 
immunity control. To this effect, we targeted the IL-4Rα on Foxp3 cells to evaluate their 
gain/loss of function during Mtb infection in mouse. 
Since our laboratory had previously shown that the absence of IL-4Rα on T reg during 
Schistosoma mansoni negatively influence the outcome of the disease (Aziz et al. 2018). This 
coupled with observed Th1 effector phenotype during Lm in mice could be a potential indicator 
or outcome in Mtb infection. Both TB and Listeriosis are intracellular pathogens and share 




3.2.3 IL-4Rα transcript enhanced expression as a predictor during TB treatment 
Whole transcriptomics via microarrays and RNA sequencing (RNA-Seq) techniques are 
regularly used to study gene expression profiling to holistically understand the host response to 
Mtb infection as a predictive tool to monitor TB disease, marker, treatment and/or outcome. 
Here, we exploited publicly available data on IL-4Rα and Foxp3 genes to understand the 
dynamics during the course of the disease in humans. The mRNA expression of the Il4rα gene 
in a South African cohort significantly increased in active TB patients (aTB) compared to 
latently infected TB controls (Figure 3.17A). Remarkably standard anti-TB treatment 
significantly reduced the expression of Il4rα in patients with TB after 48 weeks (Figure 3.17B), 
suggesting that IL-4Rα could be possibly used as a biomarker to evaluate the progression of 
treatment outcome. In addition to IL-4Rα, the expression of Foxp3 slightly increased during 
active TB (Figure 3.17C). During treatment; however, there were no significant differences 






Figure 3.17: Transcriptional signature profile of Il4rα and Foxp3 mRNA in whole-blood of active 
TB and latently infected controls in the South African cohort. Il Il4rα and Foxp3 expression data 
from whole blood were sourced from publicly available dataset (A) gene expression of Il4rα, (C) Foxp3 
in active TB and latently infected controls. Whole blood (B) Il4rα and (D) Foxp3 expression profile 
from a longitudinal cohort that follows up till the completion of anti-TB treatment. Data is generated by 
plotting signal intensity (a.u) and analysed by unpaired, Student t-test (A,C) and by one-way ANOVA 






3.2.4 IL-4Rα signalling on Foxp3 is not decisive for Mtb bacterial burden and pathology 
control in mice 
With a relatively stable expression of Foxp3 in the blood and differences in IL-4Rα expression 
during the course of treatment, we hypothesize that the deletion of IL-4Rα on Foxp3 T reg cells 
in mice affects the outcome of Mtb infection. 
To elucidate the role of IL-4Rα signalling on Foxp3 T reg, mice were infected with a sub-lethal 
Mtb H37Rv at a dose of 100 CFU/mouse by aerosol. We performed survival studies and time 
course experiments to sacrifice at 3 and 18 weeks post-infection. We found no significant 
differences in bacterial burdens in the lungs and spleen at both 3 (Figure 3.18A) and 18 weeks 
(Figure 3.18B) post-infection. At these time points, lung histopathology was comparable 
between Foxp3creIL-4Rα-/lox mice measured by hematoxylin and eosin stain (H&E) (Figure 
3.18E). Furthermore, quantification of free alveolar spaces to assess lung pathology and 
granuloma size did not reveal significant differences between groups (Figure 3.18F). To further 
investigate the effect on the survival of mice, we found no survival benefit (Figure 3.18C) and 
body weights change (Figure 3.18D) in these mice when compared to littermate control 
animals after 65 weeks. This suggests that deletion of IL-4Rα signalling on Foxp3 T regulatory 
cells have no effect during H37Rv infection. 
 
Figure 3.18 Deletion of IL-4Rα signalling on Foxp3creIL-4Rα-/lox mice does not alter bacterial 
burden and pathology: Control littermates (IL-4Rα-/lox) and Foxp3cre IL-4Rα-/lox mice were infected by 
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aerosol with 100 CFU/mouse of Mtb H37Rv (n=6 mice/group) mice sacrificed at 3 and 18 weeks post-
infection (wpi). (A) The bacterial burden of lungs and spleen at 3 wpi, (B) bacterial burden at 18 wpi, 
(C) survival curve for 65 weeks post-infection. (D) Body-weight change for the mortality study. (E) 
Representative image of H&E histopathology staining, (F) quantification of alveolar spaces. Error bars 
signify mean ± SEM. Data revealed are representative of two independent experiments. Data is 
analysed using unpaired, student t-test*, P≤0.05; **, P ≤ 0.01; ***, P≤0.001. 
  
3.2.5 Foxp3creIL-4Rα-/lox mice had no effect in lung cytokine profile relative to littermate 
control during Mtb infection 
 We investigated whether the absence of IL-4Rα on Foxp3 T reg mice (Foxp3creIL-4Rα-/ lox) on 
the lung cytokine profile in tissue homogenates, at 3 and 18wpi. We found a significant 
decrease in Nitric oxide (NO) in the Foxp3creIL-4Rα-/lox mice, this may explain an increasing 
trend in bacterial burdens. However, there was a slight increase in IGF-1 and IL-23 at 18wpi in 
the Foxp3creIL-4Rα-/lox mice at both time points. The role of IGF-1 in Mtb infection has not 
been well documented. IL-23 has been shown to contribute to initiation Th17 responses 
however, IL-17 was not affected. The role of IL-17 during Mtb infection is not well 
understood. During BCG vaccination, no differences in IL-17 have been observed (Gopal et al. 
2012) however IL-17 in chronic stages of TB can contribute to pathological inflammation 
(Cruz et al. 2010). There was an impaired production of GM-CSF in the Foxp3creIL-4Rα-/lox 
mice, GM-CSF signalling is known to be highly activated during Mtb infection. However, 
neutralising GM-CSF had no effect on bacterial burden in mice models. Lack of GM-CSF led 
to increasing in granuloma formations in mice models (Benmerzoug et al. 2018) but increased 
GM-CSF concentrations had no major effect. Furthermore, no differences were observed in IL-
12p40, IL-17, IL-4, IFN-γ, IL-12p70, IL-6, IL-1α, IL-10 and TGF-β at both time points (3 and 
18wpi). Furthermore, we examined the chemokines CXCL1, CCL3, CXCL10, CXCL2 and 
found no differences. However, there was an increase in CXCL5 at 3wpi for the Foxp3creIL-
4Rα -/lox mice. Overall, this shows that absence of IL-4Rα signalling on Foxp3 T regulatory 
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Figure 3.19: Lung homogenate cytokine/chemokine profiles in Mtb H37Rv infected Foxp3creIL-
4Rα -/lox mice and littermate control. Mice were infected with 100 CFU/mouse with Mtb H37Rv by 
aerosol and sacrificed at 3wpi and 18wpi, and lung cytokines were determined by ELISA: (A) Nitrite 
Oxide(NO), (B) Igf1, (C) IL-4, (D) IL-17, (E) IL-23, (F) IFN-γ, (G) lL-12p40, (H) IL-10, (I) TGF-β, (J) 
IL-6,(K)  IL-1α, (L) GM-CSF, (M) CXCL1, (N) CCL3, (O) CXCL10, (P) CXCL2,(Q) GCSF (R) 
CXCL5. (S) and TNF Error bars signify mean ± SEM. These results are an illustration of two similar 
experiments. Data is analysed using unpaired, student t-test *, P≤0.05; **, P ≤ 0.01; ***, P≤0.001; 
 
3.2.6 Cytokine production from mediastinal lymph nodes shows a pro-inflammatory 
cytokine profile in Foxp3creIL-4Rα -/lox mice. 
Mediastinal lymph nodes are the most commonly infected organ apart from the lungs during 
Mtb infection. Cross-talking between the antigen-presenting cells and T cells and consequent 
activation is initiated at the mediastinal lymph nodes. We collected lymph nodes from Mtb-
H37Rv infected mouse at 3 and 18wpi, surface stained for CD4+ T cells and CD8+ T cells. 
Intracellular cytokine staining was performed after ex vivo stimulation. Though no major 
differences were observed for the immune cell frequencies at the lungs, we pursue the lymph 
node where deletion IL-4Rα on T regs was pronounced. No significant differences in CD4+ T 
cell cytokines were observed at 3wpi with IFN-γ, IL-10, and IL-4. At 18 wpi, CD4+ T and 
CD8+ T cells were analysed for IFN-γ, IL-2, IL-17, TNF, IL-4, and IL-10 production. Cells 
were stimulated with Mtb cell lysate (H37Rv, BEI Resources) or PMA/Ionomycin followed by 
Monensin blockade or left unstimulated. Foxp3creIL-4Rα-/lox mice showed no differences in 
IFN-γ, IL-2, IL-17, TNF, IL-4 and IL-10 cytokine secretion when left unstimulated on both 
CD4 + T cells (Figure 3.20A) and CD8+ T cells (Figure 3.20D). However, as expected with 
H37Rv lysate stimulation, CD4+ T cells produced significantly higher IFN-γ, IL-17 and TNF in 
Foxp3creIL-4Rα-/lox mice (Figure 3.20 B) and CD8+ T cells decreased IL-4 and IL-10 (Figure 
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3.20E). Stimulation with PMA/ionomycin led to significant secretion of IL-17 and TNF for 
CD4+ T cells (Figure 3.20C) and a significant increase in IFN-γ and TNF levels for CD8 T 
cells (Figure 3.20F). Similarly to Listeriosis, the deletion of the IL-4Rα on Foxp3 T cells was 
more significant in the lymph nodes suggesting more activity at the secondary lymphoid 
organs. This increased IFN-γ, IL-17 and TNF cytokines secretion by Foxp3creIL-4Rα-/lox T 




Figure 3.20: Intracellular cytokine profile in mediastinal lymph node T cells during Mtb infection: 
Mice were infected by aerosol and sacrificed at 18wpi. A single-cell suspension of total mediastinal 
lymph nodes was prepared, and 2 million cells were then seeded to either to determine the frequency of 
cytokine production IFN-γ, IL-2, Il-17, TNF, IL-4 and IL-10 (A&D) cells in media, (B&E) after H37Rv 
lysate stimulation, and (G&F) after PMA/ionomycin stimulation. Results represent 6 mice per group 
and representative of two experiments. White bars represent Foxp3creIL-4Rα-/lox while black bars their 
littermate control (IL-4Rα-/Lox). Data are denoted as mean ± SEM, analysed using unpaired, student t-




3.2.7 Deletion of IL-4Rα on Foxp3 T reg cells influences immune cellular population 
lymph node in early H37Rv Mtb infections. 
To further understand whether the abrogation of IL-4Rα signalling on Foxp3 T reg alters the 
immune cell populations at 3 wpi. Mediastinal lymph nodes were harvested and stained for the 
presence of myeloid and lymphoid cells and acquired on the Fortessa. There was a significant 
increase in total cell numbers in Foxp3creIL-4Rα-/lox mice (Figure 3.21A) suggesting increased 
infiltration of immune cells into the lymph nodes early during infection at 3wpi. No differences 
were observed in the myeloid populations (Figure 3.21B). A significant increase in CD4+ and 
CD8+ T cells at the mediastinum lymph node (Figure 3.21C). We next sought to investigate if 
the deletion of IL-4Rα on T reg affected naïve; effector and central memory CD4 T cells in the 
Foxp3creIL-4Rα -/lox mice. There was a significant increase in CD4 effector T cells in the 
Foxp3creIl-4Rα-/lox. These results suggest the absence of IL-4Rα signalling on Foxp3 T 




Figure 3.21: Cellular population of lymph node in Foxp3creIl-4Rα-/lox mice during Mtb infection at 
3 wpi: Mice were infected with low dose (100CFU/mouse) H37Rv and sacrificed at 3wpi to determine 
immune cell using flow cytometry and analysed with Flowjo to quantify the populations in mediastinal 
lymph node. (A) Mediastinal lymph node total cell numbers (B) myeloid cell population (C) CD8/CD4 
T cell population (D) mediastinal lymph node naïve, central, and effector T cell subsets. Results are 
representative of two independent experiments (n=5-6 per group) Error bars signify mean ± SEM. Data 
revealed are representative of two independent experiments. Data is analysed using unpaired, student t-
test;*, P≤0.05; **, P ≤ 0.01; ***, P≤0.001;  
3.2.8 I IL-4Rα-mediated signalling on Foxp3 T reg cells influences the immune cell 
population in lymph node in chronic Mtb infection.  
Similar to the acute stage (3wpi), we sought to determine the immune cell populations at a 
chronic stage (18wpi) of Mtb infection. Mediastinal lymph node single-cell suspension was 
obtained and stained for myeloid and lymphoid cell populations. No differences in the cell 
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numbers in the lymph node were observed (Figure 3.22A). Similar to 3wpi, there were no 
differences in the myeloid population (Macrophages, dendritic cells, and neutrophils) (Figure 
3.22B), however consistent with 3wpi, a significant increase in CD8+ and CD4+ T cell 
population in the lymph node for the Foxp3creIl-4Rα-/lox mice (Figure 3.22C). We observed a 
significant increase in the effector and central CD4+ T cell memory in FoxP3creIL-4Rα-/lox mice 
compared to littermate control (Figure 3.22D, E and F). The increase in effector CD4 T cells 
correlated with an increase in different intracellular cytokines observed during this time. These 
results suggest that the absence of IL-4Rα signalling on T reg possibly affects effector T cells 






Figure 3.22 Cellular population of Foxp3creIl-4Rα-/lox mice during Mtb infection at 18 wpi: Mice 
were infected with low dose (100CFU/mouse) H37Rv and sacrificed at 18 wpi to determine immune 
cell using Flow cytometry and analysed with Flowjo population in mediastinal lymph node. (A) Total 
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cell numbers (B) myeloid population (C) CD8/CD4 T cell population (D) CD4 T effector, naïve and 
central cell numbers (E) Represented percentage of flow cytometry of CD4 T effector naïve, Central 
cells (F) Mediastinal lymph cell numbers Naïve, Central, Effector T cell. Results are representative of 
two independent experiments (n=5-6 per group) Error bars signify mean ± SEM. Data is analysed using 
































The Listeria monocytogenes infection in mice model has been widely studied to understand the 
immunological responses against intracellular pathogens (Pamer 2004; Hamon et al. 2006).  To 
understand the basic mechanisms of immune responses to pathogenesis, we use Lm and Mtb 
infections in mice model for possible translation into therapeutic and vaccine approaches. 
These models are commonly used to assess the Th1 immune responses to inflammation. These 
two models are related and Lm is used to understand T cell dynamics. Recent studies have 
shown the use of Lm strains fused with ESAT-6 protein of Mtb for the design of safety and a 
protective vaccine against tuberculosis (Yin et al. 2017).  
During Lm infection in mice, early control is carried out by the innate immunity most notable 
the neutrophils and macrophages which account for bacterial killing (Seki et al. 2002; Witter et 
al. 2016; Lücke et al. 2018). However, despite this important role by myeloid cells, a potent T 
cell response is necessary for maintained clearance and development of life-long protective 
immunity, largely orchestrated by CD8+ T cells (Busch et al. 1998; Sun & Bevan 2003). CD8+ 
T cells recognise Lm in the cytosol and induce clearance, while the CD4+ T cell response 
maintains a robust memory T cell responses and confer sterilizing immunity (Harty & 
Badovinac 2002; Lara-Tejero & Pamer 2004). CD4+ T cells produce Th1 cytokines mainly IL-
12, IFN-γ and TNF that mediate the potentiation of Lm clearance (Hsieh et al. 1993).  T cells 
specific response analysis involves a more complex differentiation and contraction of T cells 
into effector and central memory which are important for clearance after reinfection (Mercado 
et al. 2000). T cells plasticity allows them to change to various T cell subsets in response to 
pathogens with cytokine production. This event is flexible, extraordinarily diverse, and not 
terminally differentiated as previously thought (Talwar et al. 2013). This trend of events is 
defined by transcriptional factors such as signal transducer activator of transcription (STAT-1) 
and T box (t-bet) which are biased towards a Th1 response. Similarly, STAT-6 and STAT-5, 
control the master Th2 GATA-3 transcriptional factor (Annunziato & Romagnani 2009). 
Th1/Th2 lineages are associated with the production of IFN-γ and IL-4 cytokines respectively 
(Arun et al. 2011). Th17 cells are characterised by the retinoic acid-related orphan receptor 
(RORγt) transcriptional factor signature and produce IL-17, plasticity from Th17 to T reg with  
Forkhead box P3 (Foxp3) have been shown to alter among them depending on the conditions 
(Sawant & Vignali 2014). TGF-β, IL-4, and IL-23 have been shown to drive Th17 to T reg 
cells while IL-5 and IL-21 have been shown to move from T reg to Th17 cells (Lee et al. 
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2009). Th17 cells enhanced Th1 cells mediated by IL-12 cytokine environment (Lee et al. 
2009; Bending et al. 2009). Foxp3 regulatory T cells have been shown to undergo plasticity to 
a Th1 or Th2 depending on the cytokine milieu (Komatsu et al. 2009; Zhou et al. 2009). 
Studies have clearly shown a detrimental role of T reg cells during certain bacterial infection, 
due to simultaneous expansion of Th1 and T reg. (Scott-Browne et al. 2007; Shafiani et al. 
2010; Johanns et al. 2010; Rowe et al. 2011)  
Recently, the role of IL-4Rα on Foxp3 T regulatory cells was established on Th2 disease 
models. IL-4Rα on T reg was required for the conversion of T reg cells to Th2 cells in vitro and 
in vivo during Heligmosomoides polygyrus infection (Pelly et al. 2017). Furthermore, during 
Schistosoma mansoni infection, IL-4Rα signalling on Foxp3 T reg cells was demonstrated to be 
necessary to control exacerbated inflammation (Aziz et al. 2018). However, the role of IL-4Rα 
on Foxp3 T reg cells on Lm and Mtb infection has not been elucidated. In this study, we asked 
whether deletion of IL-4Rα on Foxp3 T cells effects the effector/Treg balance during Lm and 
Mtb infections. The proportion of T reg and effector T cells can define the outcome of 
infection.   
The Lack of human cohort studies on Listeriosis due to the inability to trace the source of 
infection and the difficulty of estimating incubation periods (Goulet et al. 2013) warranted us 
to use transcriptional mice studies to understand the dynamics of the expression of mRNA IL-
4Rα/Foxp3 in spleen and liver, over the course of infection. (Figure 3.1). Significant increase 
in IL-4Rα expression during the disease progression shows the dynamics during infection. We, 
therefore, choose acute ( 3 days ) and chronic (7 days) post-infection reflective of innate and 
adaptive phases of the disease for Lm in vivo infections (Busch et al. 1998; Zenewicz & Shen 
2007). These dynamics were similar to Mtb-infected human cohort studies which showed 
increased expression of IL-4Rα mRNA in blood of TB (Berry et al. 2010; Maertzdorf et al. 
2011; Bloom et al. 2013; Cliff et al. 2013).  
The role of IL-4 and IL-13 as type 2 cytokines which are pivotal in antagonising Th1 
cytokines. However, the role of IL-4 on T regs remains inconclusive. Studies have suggested 
beneficial role of IL-4 on CD4+ CD25+ T regs (Prochazkova et al. 2009).On the other hand IL-
4 presence depends the differentiation process of induced Tregs thereby deregulating their 
Foxp3 function (Dardalhon et al. 2008).  The absence of IL-4Rα on Foxp3 T reg cells during in 
vivo settings led to a better understanding of the necessity of these cells during the clearance or 
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reduction in bacterial burdens, and also on the survival of the mice during Lm infection. 
Interestingly, this result tie with studies in which IL-4 production was considered harmful 
during listeriosis in mice (Emoto et al. 1997). IL-4 signalling has been considered detrimental 
during Lm infection since prior administration of anti-IL-4 antibody to mice drives bacterial 
clearance during Lm infection in mice (Haak-Frendscho et al. 1992; Wagner & Czuprynski 
1993; Szalay et al. 1996). This dynamics of IL-4/IL-4Rα on Lm has been demonstrated only on 
a global knockout or transient ablation using anti-IL-4. Our laboratory has recently focused 
more on exploring and unravelling a novel role of cell-specific IL-4Rα knockdown in different 
disease models such as schistosomiasis (Aziz et al. 2018), allergy (in preparation) as well as 
Lm and Mtb infections which are the main focus of this project.  
In order to better understand this phenomenon, we observed the quality of Foxp3 was 
significantly decreased in mouse lacking IL-4Rα on Foxp3 T regulatory cells, signifying that 
IL-4Rα is required to maintain the stability and probably the function of T regulatory cells 
during Lm infection. The quality of Foxp3 T cells is affected by signals from antigen, and 
cytokines production (Dowling et al. 2018). The decrease of Foxp3 T cells tilts and strengthens 
the immune balance to an effector Th1 phenotype which is fundamental for Lm pathogenic 
clearance (Zenewicz & Shen 2007). This was quite remarkable when we found a significant 
decrease in the expression of Foxp3 at 3 dpi (Figure 3.3A) and 7 dpi (Figure 3.3B) in the 
spleen, but not in the liver tissue. This suggests that although the Foxp3 T regulatory 
population is not affected by the loss of IL-4Rα at a steady-state, during infection the quality 
and possibly the function of Foxp3 T regs are affected. Foxp3 instability has shown transient 
changes from Foxp3 T cells to Th2 (exFoxp3 T cells), which proliferates in tissues and produce 
inflammatory cytokines  (Zhou et al. 2009). Furthermore, we observed a significant increase in 
T-bet in the Foxp3creIl-4Rα-/lox mice, demonstrating a possible indicator of enhanced Th1 due 
to loss of Foxp3 T cell population. This is speculative since we did not use a multigene reporter 
and fate-reporter sysytems mice to demonstrate the shift from Foxp3 regulatory T cells to 
exFoxp3 (Th1) as in Heligmosomoides polygyrus infection which to show a shift from 
exFoxp3 to Th2 (Pelly et al. 2017). Tilting this balance has been shown to play an important 
beneficiary function most notable in Listeria monocytogenes, and Salmonella enterica where 
near-total depletion of Foxp3 T reg cells was achieved (Johanns et al. 2010; Rowe et al. 2011, 
2012). However, we demonstrated that the lack of stability was due to the loss of IL-4Rα, the 
effector T cells in Foxp3creIL-4Rα−/lox mice were significantly increased during Lm infections, 
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therefore, asserting the imbalance witnessed. This interplay is fundamental as the ratio of 
regulatory CD4+ T cells and the effector immune cells are key to host response (Wing & 
Sakaguchi 2010). Foxp3 regulatory T cells population is also known to impede the priming of 
effector T cells (Ertelt et al. 2009, 2011; Eisenstein & Williams 2009; Omenetti & Pizarro 
2015). 
IL-4Rα signalling on T reg cells is essential to maintain T reg and loss of IL-4Rα on T reg 
leads to increase CD8+T cells in Foxp3creIL-4Rα-/lox mice. IL-12 IFN-β, IFN-α, secreted from 
myeloid cells, which are able to activate CD8+ T cells and expansion in vitro, however, in in 
vivo setting, these cytokines where non-essential towards the activation and expansion of  
CD8+ T cells in Lm infection in vivo, (Curtsinger et al. 2003, 2005). Previously, it has been 
reported that during Lm infection Foxp3 T reg cells' impeded the activation and expansion of 
CD8+T cells, and deletion of T reg leads to expansion of CD8+ T cells (Ertelt et al. 2011). We 
observed a significant increase in CD8+ T cells when IL-4Rα was absent on Foxp3 T cells. 
CD8+ T cells are very crucial for Lm infection (Tvinnereim et al. 2002; Shedlock et al. 2003; 
Hamon et al. 2006; Zaiss et al. 2008; Condotta et al. 2012) This possibly explain the reduced 
listerial burdens, we observed in Foxp3creIL-4Rα-/lox mice. 
CD8+ T cells are known to secrete granzyme B and perforin during effector function and 
vaccination of host, which is developed during CD8+ T cell proliferation into cytolytic T 
lymphocytes in response to antigen (Mouchacca et al. 2013). This is achieved by the directed 
release of granzyme B by CD8+ T cells, though mechanistically, the deficiency of IFN-γ as an 
effector cytokine affects killing during primary infection more than the immediate of the direct 
effect of granzyme B (Messingham et al. 2007). So, though we experienced higher secretion of 
granzyme B, we rather looked for the expression of IFN-γ in splenic T cells during this time 
frame. At 7 dpi Lm infection, there was a significant increase in IFN-γ in the serum, increase in 
IFN-γ upon αCD3 re-stimulation of the splenocytes and IFN-γ produced by CD4+ and CD8+T 
cells. Increased splenic IFN-γ at day 6 post-infection has been shown to correlate with 
clearance of Lm in the spleen and peritoneal cavity, though IFN-γ secretion was not exclusively 
secreted by T cells, with the early release coming from NK cells (Buchmeier & Schreiber 
1985; van Dissel et al. 1987; Thäle & Kiderlen 2005). Similar to granzyme B, IFN-γ, secretion 
alone is necessary but not indispensable for host killing effect. (Leenen et al. 1994).  At 3dpi, 
we did not observe significant differences in the levels of in IFN-γ, IL-10, and TNF. At 7dpi, 
there was a significant increase in IFN-γ and IL-10 when stimulated with anti-CD3 and a 
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similar trend was observed in HKLM stimulation at 7 dpi (Figure 3.7D-E). This might explain 
a modest effect in bacterial burdens and histology on day 3, and hence the cytokines. However, 
the major cytokine differences were observed at day 7 was IL-2 which was significantly 
increased concomitantly with IFN-γ upon stimulations. IL-2 controls the expression of 
transcriptional factors, hence contributing to Th1 cell development (Liao et al. 2011). It is also 
known to maintain T reg cells and effector T cell differentiation and control of cytokine 
secretion (Wang & Secombes 2013; Arenas-Ramirez et al. 2015; Mitra & Leonard 2018). IL-2 
significantly increased in the Foxp3cre IL-4Rα−/lox mice during Lm infection was also correlated 
with effector and Th1 cytokines as described above with conspicuous T-bet Th1 transcriptional 
factor. IL-2 is known to maintain the functional stability of T reg, though there were decreased 
in T reg during infection, the increase in IL-2 probably helped maintain T reg cells that had lost 
the IL-4R.  
The innate response was affected by the absence of IL-4Rα on Foxp3. Primary infection is 
fought by the myeloid cells in the spleen and liver by the splenic marginal zone of the red pulp 
(Conlan 1997; Condotta et al. 2012), but the T-zone of the white pulp is where effector T cells 
probably cross-talk with dendritic cells (Aoshi et al. 2008; Edelson et al. 2011). In Foxp3creIL-
4Rα-/lox mice, we observed less destruction of white pulp during Lm infection suggesting 
improved control during an adaptive response. Cellular depletion of white pulp during Lm 
infection indicated a critical role of myelomonocytic cells interactions with CD8 T cells at 
effector (Waite et al. 2011). An increase in neutrophils at both time points was also observed in 
Foxp3creIl-4Rα-/lox mice. Neutrophils are known to play an important protective role by 
producing cytokines that potentiate killing of the Lm (Carr et al. 2011; Witter et al. 2016). 
Neutrophils are known to appear within the first 24 hours and depletion using monoclonal 
antibodies concluded that the neutrophils are essential during Lm infection. (Rogers & Unanue 
1993; Conlan & North 1994; Czuprynski et al. 1994; Conlan 1997). The use of anti-Ly6G 
monoclonal antibody for neutrophils has also established this role of neutrophils (Edelson et al. 
2011a; Carr et al. 2011). Increase in neutrophils, in Foxp3creIL-4Rα−/lox mice increase could 
possibly explain reduced bacterial burden as well as cellular infiltration in histopathology of 
spleen and liver. This suggests that there was increased recruitment of immune cells in the 
spleen, this was also true for inflammatory macrophages (7dpi) in the Foxp3creIL-4Rα-/lox 
(Figure 3.9) in which we observed and significant increase. At the liver, there was less 
recruitment of macrophages at both time points. IL-12 secreted by macrophages and NK cells 
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promote the development of Th1 cells, whereas IL-4 is well known for the development of Th2 
cells. (Bancroft et al. 1991; Hsieh et al. 1993; Scott 1993; Locksley 1993; Seder & Paul 
1994b). There was a slight increase in the recruitment dendritic cells at the early time point 
(3dpi) for the Foxp3creIL-4Rα-/lox mice in the spleen, however, no differences were observed in 
both groups at the later time point. Neutrophils (GR1+CD11b+Cd11C-) were also significantly 
increased at the spleen but not in liver for the Foxp3creIL-4Rα-/lox mice. The role of neutrophils 
in diseases has been shown to be both detrimental and protective depending on the disease. 
During vaccination and re-challenged (Figure 3.15), infection with of Foxp3creIl-4Rα-/lox mice 
with Lm revealed a totally different phenotype on the role of IL-4Rα on Foxp3. The 
Foxp3creIL-4Rα-/lox mice were highly susceptible compared to primary infection. (Figure 3.4). 
A possible explanation is that Lm infection is a fast model (adaptive immunity sets in 4 to 
5days) (Zenewicz & Shen 2007). During the primary phase, the absence of the receptor affects 
the dynamics of Foxp3 T cells (Figure 3.3).  This affects the expression of cytokines, most 
notable IFN-γ at the spleen (Figures 3.7, 3.8 and 3.10). Secretion of IFN-γ has a beneficiary 
effect during Lm infection (Haak-Frendscho et al. 1992; Szalay et al. 1996; Andersson et al. 
1998; Thäle & Kiderlen 2005; Messingham et al. 2007; Yin et al. 2017). However, protracted 
infection, the loss of IL-4Rα and the resultant effect on the Foxp3 become detrimental as 
evidenced on longer models (Pelly et al. 2017; Aziz et al. 2018). This susceptibility was 
matched with increased spleen and liver burdens and H&E histopathology. A significant 
amount of IFN-γ, IL-10, TGF-β and IL-12p40 was secreted in liver homogenate cytokine of 
Foxp3creIl-4Rα-/lox mice. The observation consistent with Aziz and colleagues, where they 
described a significant increase of cytokines in the liver, possibly accounting for tissue damage. 
In addition, at the spleen, there was a reduced secretion of IFN-γ with a corresponding 
increased secretion of immunosuppressive cytokines, a possible indication of inhibition of IFN-
γ. In the absence of CD4+ T cells, naïve CD8+ T cells respond very well to Lm infection during 
primary infection and clear off Lm, however, during secondary immunization mice lacking 
CD4+ T cells with potent CD8+ T cell memory showed defective ability to respond to a second 
encounter with the antigen (Sun & Bevan 2003).  Due to loss of IL-4Rα on CD4+ T Foxp3 
regulatory T cells, this may have affected CD4 T cells hence during rechallenge could not 
mount a sustainable control similar primary infection. 
In order to mechanistically determine the phenotype observed during primary Lm, co-culture of 
T cells derived from Foxp3creIl-4Rα-/lox mice with Listeria (HKLM) exposed macrophages 
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(BMDM) were cultured in the presence of HKLM antigen for during 72 hours. T regs 
(CD4+CD25+) cells from sorted for Foxp3creIl-4Rα-/lox mice showed significant CD4 T cell 
effector (CD44+CD62L-) phenotype, similar to in vivo listeriosis and tuberculosis. Interesting 
the percentage of CD4+Foxp3+ T cells was also significantly reduced from cells from sorted 
from Foxp3creIl-4Rα-/lox mice in conformity with Foxp3 cells in Figure 3. This translate into a 
loss of IL-4Rα on Foxp3 T cells results in reduced Foxp3 expression in Foxp3creIl-4Rα-/lox mice 
and more effector function. This is reflective in studies where CD4+CD25+ has been shown to 
suppress Foxp3 expression during Lm infection (Hussain & Paterson 2004; Ma et al. 2007; 
Ertelt et al. 2009a). Quite interestingly, the amount of IL-10 was significantly decreased in 
Foxp3creIL-4Rα-/lox mice (Figure 15I). Suggesting less suppressive activity of IL-10 during Lm 
infection.(Laidlaw et al. 2015). This was quite expected as we had more effector T cells in 
Foxp3creIl-4Rα-/lox mice. However, we did not observe any difference in IFN-γ (Figure 3.15H) 
in vivo, suggesting other factors and/or source of cytokine play a role in to IFN-γ secretion.  
During Mtb infection with H37Rv, we did not observe any differences in bacterial loads during 
the acute and chronic phase of infection (Figure 3.17).  However, deletion of IL-4/IL-4Rα in 
mice studies have demonstrated varying results. For example, during L. major IR17 3 infection, 
IL-4-/- deletion in mice demonstrated control of the parasite through IL-4Rα, this was not 
through an alternative shift in Th1 with the production of IFN-γ during the acute infection 
(Noben-Trauth et al. 1999) However, IL-4 secretion during the chronic stage suppressed host 
protective Th1 response (Biedermann et al. 2001). Increase of IL-4 cytokine production from 
CD4+ and CD8+ T cells have increased with patients with pulmonary tuberculosis (van Crevel 
et al. 2000; Ordway et al. 2005; Mihret et al. 2012). In Mtb infection IL-4-/- mice or  IL-4 
neutralisation using antibodies has been shown to result in reduced bacterial loads and 
improved histopathology (Hernandez-Pando et al. 2004; Roy et al. 2008). Additionally, the use 
of neutralising anti-IL-4 antibody administered in mice during early or late stages have been 
shown significant reduction in bacterial burden (Roy et al. 2008), suggesting the shift in the 
Th1/Th2 axis may play a potential role in effector killing during infection. Our results did not 
confirm to this paradigm. A possible explanation is likely different pathogenesis, slowly 
growing nature of Mtb in addition to likely the less virulence of the H37Rv strain. In BALB/c 
mice, and in humans studies, Mtb infection is associated with increase in the levels of IL-4 
from CD4+ T cells and CD8+ T cells during the chronic phases (Seah et al. 2000; van Crevel et 
al. 2000; Smith et al. 2002; Lienhardt et al. 2002).  Consistently, in human cohort studies, we 
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found increased IL-4Rα mRNA transcripts from the publicly available datasets. In human 
cohort studies, there was a significant increase in the IL-4α receptor in active TB patients 
compared to latent patients. This was similar to the Gambia cohorts and the UK cohort. Though 
the increase in all cohorts, was significant, increases in African cohorts have been suggested to 
emanate from concomitant helminths infections in these settings more than in the UK settings 
(Rook et al. 2004).  Pre-existing helminths have been shown to inhibit pulmonary anti-TB 
defence by the IL-4Rα signalling (Potian et al. 2011). IL-4Rα decreased during the course of 
treatment and reverted to the levels of latently infected control individuals prior to treatment, 
suggesting the Il-4Rα could be used as a potential marker to monitor the progression to disease.     
Loss of IL-4Rα on Foxp3 T regulatory cells diminished the quality measured with geometric 
fluorescent intensity (GMFI) of Foxp3. Most interestingly, this also translated into an effector 
T cell balance during Mtb infection. This confirmed the fact that decrease in Foxp3 T cells 
shifts the balance, confirming the role of IL-4Rα on the stability of T regulatory cell 
population. To better confirmed this, mediastinum lymph node stimulation with H37Rv lysate 
and PMA/ionomycin. This led to a significant increase in CD4+ T cell producing, IL-17, TNF 
with IFN-γ produced only with Mtb lysate. Though we had a significant increase in CD4+ and 
CD8+ T cells this did not translate into changes or improved lung pathology or bacterial 
burdens. Therefore, despite enhanced T cells, other factors or cell population play a role in Mtb 
infection. 
It would appear IL-4Rα on Foxp3 T cells may not be contributing to controlling Mtb during the 
early and late phase of infections but affect the effector T cells similarly to Lm infection. We 
suggestion this discrepancy between these two models might be due in part that; in the Lm 
model, there was a significant increase in neutrophils, and as discussed above, neutrophils are 
known to play a beneficial role during early Lm infection (Conlan 1997), conversely, increase 
neutrophils have been shown to be detrimental during Mtb infection owing to the fact that there 
are the first cells to migrate to the site of infection (Eruslanov et al. 2005). Also, CD8+ 
cytotoxic T cells play an essential and predominant role during Lm infection (Lara-Tejero & 
Pamer 2004; Condotta et al. 2012) due to the recognition of specific epitopes in MHC-1 
cytosolic presentation(Shen et al. 1998). On the other hand, CD8+T cells play a role in Mtb 






Figure 4.1 Proposed model on gain/loss of IL-4Rα on CD4+ T Foxp3 during Lm infection 
During infection, macrophages phagocytise the Lm and produce IL-12 that recruits other myeloid cells 
and present it to naive CD4+ T cells to produce IFN-γ and other cytokines including IL-2  Presence of 
IL-4Rα on CD4 T Foxp3 maintains Foxp3 T reg during Lm infection. However, loss of IL-4Rα leads to 
the loss of a percentage of Foxp3 T reg thereby shifting the balance towards a more effector T cell. 
Effector T cells are characterised by the presence of T-bet transcriptional factor hallmark of Th-1 
responses. Th-1 secrete IFN-γ and IL-4 that probable activates macrophages to kill Lm during infection.     
 
In conclusion, several studies had demonstrated the detrimental role of IL-4/IL-4Rα signalling 
in the promotion of Th-1 immune responses. To our knowledge, no study has described a cell-
specific deletion of IL-4Rα during Lm. A Foxp3 T cell-deficient of IL-4Rα (Foxp3creIL-4Rα-
/lox) allowed us to investigate an important role of the stability of CD4 Foxp3 T reg in the 
absence of IL-4Rα during Lm infection. Infection of Foxp3creIL-4Rα-/lox mice with Lm led to 
the loss of the quality, thereby, tilting the CD4 T cell effector balance to more effector 
phenotype. Optimal immunity depends on a robust and clonal expansion of effector T cell 
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function that renders the cells to secrete cytokines that mount a rapid response to pathogens 
during infection (Zhou et al. 2009).  
These led to the production of pro-inflammatory cytokines, including IFN-γ which are essential 
for Lm clearance. Strikingly, in CD4+CD25+ T cell sorted from Foxp3creIL-4Rα-/lox mice 
confirmed an important role of the suppressive nature of T reg through the secretion of IL-10. 
In Mtb infection, we did not observe any differences in bacterial burden and histopathology. 
Future study will address whether a virulent strain of Mtb affects the outcome in this mouse 
model.However, the CD4 T effector balance was significantly altered in the absence of IL-4Rα, 
similarly to Lm infection. Together we demonstrate a novel role of IL-4Rα signalling during 
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